Full List of Publications (Last Updated Oct 2026)

Written By May Choi

Peer-Reviewed Manuscripts (Trainees underlined)

 

1.     Taremwa IM, et al [including Choi MY]. Caregivers’ and healthcare providers’ perceptions of blood availability, safety, and acceptability for patients with cancer in southwestern Uganda. PLOS Global Public Health. 2026. Accepted.

 

2.     Konstantinov KN, Konstantinov NK, de Melo Cruvinel W, Andrade LEC, Klotz W, Fritzler MJ; International Consensus on Autoantibody Patterns (ICAP) [includes Choi MY]. Autoantibodies to the nuclear envelope: Functional anatomy of the HEp-2 cell substrate. Autoimmun Rev. 2026 Aug 7;25(11):104154. doi: 10.1016/j.autrev.2026.104154. Epub ahead of print. PMID: 42567391.

 

3.     Kundakci B, Barber MRW, Clarke AE, Johnson SR, Mak A, Brunner HI, et al [including Choi MY as part of SDI Revision Literature Review Groups]. The lupus damage index revision program: Results from the item generation and reduction phases. Lupus Science & Medicine. 2026;13:e002282. https://doi.org/10.1136/lupus-2026-002282

 

4.     Goulet D, Guertin C, Larché M, Ferdinand I, Hudson M, Choi MY, Osman M, Pope J, Thorne C, Baron M; Canadian Scleroderma Research Group; Bernatsky S, Hoa S. Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care? Arthritis Care Res (Hoboken). 2026 Jun 1. doi: 10.1002/acr.80098. Epub ahead of print. PMID: 42223235.

5.     Tsegai V, Lawal H, John C, Akinrinade I, Duncan S, Dufour A, Barber CEH, Hazlewood G, Choi MY, Agbani EO. Upadacitinib enhances platelet procoagulant responses in a subset of healthy individuals and patients with SLE: a pilot study. Lupus Sci Med. 2026 Jul 7;13(2):e001983. doi: 10.1136/lupus-2026-001983. PMID: 42414040; PMCID: PMC13343016.

6.     Alkadri S, Fritzler M, Sciore P, Clarke A, Pierre Y, Twilt M, Dufour A, Muruve D, Cheema K, Li M, Choi M. Renal Inflammation Assessment using Complement Activation and CD163. InPeer Beyond Graduate Research Conference 2026 May 19 (Vol. 2, No. 1).

7.     Taremwa IM, Niyonzima N, Ashaba S, Tusubira D, Choi MY, Jenne CN, Natukunda B (2026). The Incidence of Hemolytic and Serologic Transfusion Reactions Among Patients with Hematological Malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute, in Uganda. Journal of Blood Medicine, 17:1-14. https://doi.org/10.2147/JBM.S589504. Accepted Apr 2026.

8.     Jalaledin D, El Kamouni H, Albert A, Hoa S, Bourré‐Tessier Josiane, Rich E, Goulet JR, Koenig M, Pérez G, Choi MY, Troyanov Y, Satoh M, Fritzler M, Senécal JL, Landon‐Cardinal O. (2026). Clinical Associations of Anti‐RNPC3 Autoantibodies in Mixed Connective Tissue Disease. ACR Open Rheumatology. 8:1-7. 10.1002/acr2.90035. Apr 2026

 

9.     Nikolic RP, Ben-Chetrit E, Fritzler MJ, Buhler KA, Shokravi A, Barreth NH, Chan EK, Andrade LE, Lin M, Grewal J, Buyon J, Damoiseaux J, Lee A, Steiner G, Ménard H, Boire G, Prujin G, Reeves W, Satoh M, Scofield RH, Tebo A, Wener M, and Choi MY. International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseases. Annals of the Rheumatic Diseases. 2026 May 15.

 

10.  Harvey GR, Ashur I, Bossuyt X, Bluethner M, Brusch A, Bundell C, Chinoy H, Coeshott C, Choi MY, Donald C, Dunphy J. Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies. Journal of Autoimmunity. 2026 May 1;160:103548. doi: 10.1016/j.jaut.2026.103548. Epub ahead of print. PMID: 41863861. 2026 Mar 20

11.  Levin D, Choi MY, Kawasoe J, Durand C, Osman M, Kim H, Hemmati I, Woo M, Li D, Howlett J, Li N. Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation. The Journal of Rheumatology. 2026 Apr 15.

12.  Mocanu V, Moghaddam F, Aminghafari M, Choi MY. Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases. Rheumatic Disease Clinics of North America. March 2026.

 

13.  Barreth N, Leclair V, Hudson M, Bernatsky S, Krustev E, Moran Toro C, St. Pierre Y, Clarke A, Sciore PJ, Tarnopolsky M, Fritzler MJ, Choi MY. Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies. Rheumatology. 2026 Mar 23:keag139.

 

14.  Koo R, Krustev E, Moran-Toro C, Koopman JE, Fritzler MF and Choi MY. MDA5 Antibody Testing: Rapid Results Required for Rapidly Progressive Interstitial Lung Disease.  ASCP LabQ Clinical Immunology 2026 (LQCL2604). April 2026.

15.  Taremwa IM, Niyonzima N, Ashaba S, Kemigisha E, Tusubira D, Okongo B, Nambozi G, Choi MY, Jenne CN, van Marle G, Natukunda B. Red blood cell alloantibodies in transfused patients with haematological malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute: Prevalence, specificities and associated factors. Vox Sang. 2026 Feb 10. doi: 10.1111/vox.70198. Epub ahead of print. PMID: 41667149.

16.  Yee J, Oakes EG, Santacroce L, Choi MY, Karlson EW, Koenen K, Kubzansky LD, Cui J, Feldman CH, Costenbader KH. Depression, anxiety, and post-traumatic stress disorder in association with cardiovascular disease among patients with systemic lupus erythematosus and rheumatoid arthritis in the All of Us Research Program. Clin Rheumatol. 2026 Feb;45(2):791-801. doi: 10.1007/s10067-026-07942-1. Epub 2026 Jan 16. PMID: 41545798; PMCID: PMC12833825.

 

17.  Tayer-Shifman OE, Su J, Bingham K, Kakvan M, Tartaglia MC, Ruttan L, Marzouk S, Wither J, Choi MY, Bonilla D, Appenzeller S, Beaton D, Katz P, Green R, Gladman DD, Touma Z. Intraindividual cognitive function course over time in patients with systemic lupus erythematosus. RMD Open. 2025 Dec 23;11(4):e005655. doi: 10.1136/rmdopen-2025-005655. PMID: 41436139; PMCID: PMC12730825.

18.  Fritzler MJ, Muro Y, Klotz W, Herold M, Andrade LEC, Grecco M, Satoh M, Choi MY, Infantino M, Chan EKL. Striatin-3 is a human autoantigen but it is not associated with the S-phase G2 nuclear antigen (SG2NA) staining pattern. J Autoimmun. 2026 Feb;158:103503. doi: 10.1016/j.jaut.2025.103503. Epub 2025 Nov 25. PMID: 41297092.

19.  Leclair V, Cotton T, Shen HC, Berger C, Troyanov Y, Hudson M, Gyger G; Canadian Inflammatory Myopathy Study (including Choi MY). Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets. Rheumatology (Oxford). 2026 Feb 4;65(2):keaf594. doi: 10.1093/rheumatology/keaf594. PMID: 41206056.

20.  Zhao N, Smargiassi A, Chen H, Choi MY, Fritzler MJ, Touma Z, Aviña-Zubieta JA, Bernatsky S. Fine particulate matter air pollution and anti-nuclear antibodies. Rheumatology (Oxford). 2026 Jan 8;65(1):keaf545. doi: 10.1093/rheumatology/keaf545. PMID: 41131821; PMCID: PMC12862395.

21.  Becker YLC, Boilard É, Rollet-Labelle E, Lood C, Julien AS, Abrahamowicz M, Allaeys I, Choi MY, Leclerc J, Lévesque T, Urowitz M, Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Gladman DD, Bruce IN, Petri M, Ginzler E, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcόn GS, van Vollenhoven R, Aranow C, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Buyon J, Fortin PR. Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality. Ann Rheum Dis. 2025 Dec 12:S0003-4967(25)04533-9. doi: 10.1016/j.ard.2025.11.007. Epub ahead of print. PMID: 41390302.

22.  Ye C, Nikolic RP, Choi M, Fifi-Mah AV, Graham J, O’Neil LJ, Kobza A, Lau KC, Arreola LG, Pardo JP, Ladouceur A. Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology living guidelines for baseline immunosuppression in individuals with preexisting rheumatic diseases initiating immune checkpoint inhibitors. Part 2: preexisting systemic autoimmune rheumatic diseases. The Journal of Rheumatology. 2025 Dec 1;52(12):1218-30. https://doi.org/10.3899/jrheum.2025-0482

 

23.  Ye C, Nikolic RP, Choi M, Fifi-Mah AV, Graham J, O’Neil LJ, Kobza A, Lau KC, Arreola LG, Pardo JP, Ladouceur A. Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology living guidelines for baseline immunosuppression in individuals with preexisting rheumatic diseases initiating immune checkpoint inhibitors. Part 1: preexisting inflammatory arthritides. The Journal of Rheumatology. 2025 Dec 1;52(12):1207-17. https://doi.org/10.3899/jrheum.2025-0481

 

24.  van Eeden, C., Rezaeifar, M., Elezzabi, M., Redmond, D., Gniadecki, R., Abey, A., [Choi, MY] & Osman, M. S. (2025). Severe fatigue is associated with diminished lung function and elevated galectin-9 levels in early systemic sclerosis. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1655414

25.  Muñoz‐Grajales, C., Barraclough, M., Diaz‐Martinez, J. P., Su, J., Bingham, K., Kakvan, M., [including Choi, MY] & Touma, Z. (2025). Association of elevated serum s100a8/a9 levels and cognitive impairment in patients with systemic lupus erythematosus. Arthritis Care & Research. https://doi.org/10.1002/acr.25575

26.  Sigel M, Muñoz-Grajales C, Barraclough ML, Diaz-Martinez JP, Kakvan M, Kretzmann RP, Tartaglia MC, Ruttan L, Choi MY, Appenzeller S, Bonilla D, Katz P, Beaton DE, Green R, Gladman DD, Wither JE, Flint AJ, Touma Z, Bingham KS. Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors. Semin Arthritis Rheum. 2025 Aug;73:152718. doi: 10.1016/j.semarthrit.2025.152718. Epub 2025 Apr 9. PMID: 40286553.

27.  Kim Y, Koopman JJE, Choi M, Feldman CH, Costenbader KH. Environmental Risk Factors for Systemic Lupus Erythematosus Through the Lens of Social Determinants of Health. Arthritis Care Res (Hoboken). 2025 Jun;77(6):689-699. doi: 10.1002/acr.25497. Epub 2025 Jan 25. PMID: 39800912; PMCID: PMC12122242.

28.  Shantz E, Elliott SJ, Sperling C, Choi MY. 'Information is power': A qualitative exploration of co-producing education resources about cardiovascular disease in partnership with women living with lupus. Womens Health (Lond). 2025 Jan-Dec;21:17455057251351736. doi: 10.1177/17455057251351736. Epub 2025 Jul 4. PMID: 40613440; PMCID: PMC12227901.

29.  Baron M, Nikpour M, Hansen D, Proudman S, Stevens W; Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group [including Choi, MY]; Wang M. Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual. Arthritis Care Res (Hoboken). 2025 May;77(5):640-648. doi: 10.1002/acr.25467. Epub 2025 Feb 2. PMID: 39542833

 

30.  Krustev E, Fritzler MJ, Bernatsky S, St Pierre Y, Sciore PJ, Vinet E, Pineau CA, Mendel A, Kalache F, Grenier LP, Cotton T, Niaki OZ, Choi MY. Anti-myxovirus resistance protein 1: a novel biomarker for autoimmune myositis and interstitial lung disease in systemic lupus erythematosus. Ann Rheum Dis. 2025 Feb 12:S0003-4967(25)00177-3. doi: 10.1016/j.ard.2025.01.031. Epub ahead of print. PMID: 39948002.

 

31.  Li J, Hudson M, Ye C, Roberts J, Fifi-Mah A, Choi MY, Hoa S, Appleton CT, Pope J, Maltez N, Arreola LG, Obrzut A, Jamal S; Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO). Impact of Age on Rheumatic Immune-related Adverse Events: Experience from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO). J Rheumatol. 2024 Dec 15:jrheum.2024-0603. doi: 10.3899/jrheum.2024-0603. Epub ahead of print. PMID: 39681372.

32.  Scime NV, Velez MP, Choi MY, Ray JG, Boblitz A, Brown HK. Association between infertility and incident onset of systemic autoimmune rheumatic disease after childbirth: a population-based cohort study. Human Reproduction. 2024 Dec 5:deae253.

33.  Oakes EG, Ellrodt J, Guan H, Yee J, Choi MY, Costenbader KH. Increased risk of adverse events among patients with vs. without systemic autoimmune rheumatic disease prescribed sodium-glucose cotransporter 2 inhibitors: a retrospective cohort study. Clinical Rheumatology. 2024 Dec;43(12):3839-47.

34.  Geng RS, Buhler KA, Choi MY, Croitoru D, Pope E, Fritzler MJ, Sibbald C. Serum Th1, Th2, Th17 and innate immune system biomarkers are elevated in pediatric alopecia areata with and without concurrent atopic dermatitis: A cross-sectional study. JAAD International. 2024 Oct 23.

35.  Yee J, Feldman CH, Oakes EG, Ellrodt J, Guan H, Choi MY, Karlson EW, Costenbader KH. Cost‐related Medication Behaviors for Patients with and without Systemic Autoimmune Rheumatic Diseases. Arthritis Care & Research. 2024 Sep 13.

 

36.  Choi MY, Costenbader KH, Fritzler MJ. Environment and systemic autoimmune rheumatic diseases: an overview and future directions. Front Immunol. 2024;15. doi:10.3389/fimmu.2024.1456145.

 

37.  Andrade LEC, Klotz W, Herold M, Musset L, Damoiseaux J, Infantino M, Carballo O, Choi M, von Muhlen C, Garcia-De La Torre I, Satoh M, Francescantonio P, Mimori T, Conrad K, Cruvinel W, Chan E, Fritzler M. Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop. Autoimmunity Reviews. 2024;23(9):103608. doi:10.1016/j.autrev.2024.103608.

38.  Oakes EG, Dillon E, Buhler KA, Guan H, Paudel M, Marks K, Adejoorin I, Yee J, Ellrodt J, Tedeschi S, Sparks J, Case SM, Hsu T, Solomon DH, Jonsson AH, Alexander RV, Rao DA, Choi MY, Costenbader KH. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies. J Autoimmun. 2024 Aug 2;148:103299. doi: 10.1016/j.jaut.2024.103299. Epub ahead of print. PMID: 39096716.

 

39.  Ross L, Hansen D, Proudman S, Khanna D, Herrick AL, Stevens W, Baron M, Nikpour M; Australian Scleroderma Interest Group (ASIG), Canadian Scleroderma Research Group (CSRG), the Scleroderma Clinical Trials Consortium Activity Index Working Group [including Choi, MY]. Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index. Arthritis Rheumatol. 2024 Nov;76(11):1635-1644. doi: 10.1002/art.42939. Epub 2024 Aug 26.PMID: 38937146

40.  Shantz EP, Elliott SJ, Sperling C, Buhler K, Costenbader KH, Choi MY. Towards an understanding of the biopsychosocial determinants of CVD in SLE: a scoping review. Lupus Science & Medicine 2024;0:e001155. doi:10.1136/ lupus-2024-001155.

41.  Gupta A, Johnson S, Barraclough M, Su J, Bingham K, Knight AM, Diaz Martinez JP, Kakvan M, Tartaglia MC, Ruttan L, Marzouk S, Wither J, Choi MY, Bonilla D, Appenzeller S, Beaton D, Katz P, Green R, Touma Z. Outcome clusters and their stability over 1 year in patients with SLE: self-reported and performance-based cognitive function, disease activity, mood and health-related quality of life. Lupus Sci Med. 2024 Jul 11;11(2):e001006. doi: 10.1136/lupus-2023-001006. PMID: 38991833; PMCID: PMC11243126.

42.  Nikolic RPA, Virk MK, Buhler KA, Costenbader KH, Choi MY*, Weber B* (*co-senior authors). Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients with Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis. J Cardiovasc Pharmacol. 2024 May 8. doi: 10.1097/FJC.0000000000001589. Epub ahead of print. PMID: 38922589.

43.  Koopman JJE, Buhler KA, Choi MY. From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis. Brief Bioinform. 2024 May 23;25(4):bbae303. doi: 10.1093/bib/bbae303. PMID: 38920344; PMCID: PMC11200185.

44.  Choi MY, Guan H, Yoshida K, Paudel M, Kargere BA, Li D, Ellrodt J, Stevens E, Cai T, Weber BN, Everett BM, Costenbader KH. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2024 Aug;67:152468. doi: 10.1016/j.semarthrit.2024.152468. Epub 2024 May 17. PMID: 38788567; PMCID: PMC11214838.

 

45.  Krustev E, Hanly JG, Chin R, Buhler KA, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sánchez-Guerrero J, Bernatsky S, Wallace DJ, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley MA, Ramsey-Goldman R, Manzi S, Jonsen A, Alacron G, van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askenase A, Buyon J, Fritzler M, Clarke A, Choi M. Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine. 2024 Apr 1;11(1):e001139.

 

46.  Zhan K, Buhler K, Chen I, Fritzler MJ, Choi MY. Systemic lupus in the era of machine learning medicine. 2024. Lupus Science & Medicine. Lupus Sci Med. 2024 Mar 4;11(1):e001140. doi: 10.1136/lupus-2023-001140. PMID: 38443092.

 

47.  Muñoz-Grajales C, Barraclough ML, Diaz-Martinez JP, Su J, Bingham K, Kakvan M, Kretzmann RP, Tartaglia MC, Ruttan L, Choi MY, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Gladman DD, Wither J, Touma Z. Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment. Front Immunol. 2024 Jan 25;14:1326751. doi: 10.3389/fimmu.2023.1326751. PMID: 38332909; PMCID: PMC10851148.

 

48.  Barraclough M, Erdman L, Diaz-Martinez JP, Knight A, Bingham K, Su J, Kakvan M, Grajales CM, Tartaglia MC, Ruttan L, Wither J, Choi MY, Bonilla D, Appenzeller S, Parker B, Goldenberg A, Katz P, Beaton D, Green R, Bruce IN, Touma Z. Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment. Rheumatology (Oxford). 2023 Nov 2;62(11):3610-3618. doi: 10.1093/rheumatology/keac653. PMID: 36394258; PMCID: PMC10629781.

 

49.  El Kamouni H, S Jalaledin D, Albert A, Hoa S, Vo C, Bourré-Tessier J, Rich É, Goulet JR, Koenig M, Pérez G, Choi MY, Troyanov Y, Satoh M, Fritzler MJ, Senécal JL, Landon-Cardinal O. Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype. RMD Open. 2023 Oct;9(4):e003431. doi: 10.1136/rmdopen-2023-003431. PMID: 37797966; PMCID: PMC10551952..

 

50.  Choi MY, Mosher D. Approach to management of inflammatory bowel disease-related arthritis. Can IBD Today [Internet]. 2023 Apr. 11 [cited 2023 Sep. 8];1(1):25–30. Available from: https://canadianibdtoday.com/article/view/1-1-4-choi_et_al

 

51.  Polley DJ, Latham P, Choi MY, Buhler KA, Fritzler MJ, Fritzler ML. Identification of Novel Clusters of Co-Expressing Cytokines in a Diagnostic Cytokine Multiplex Test. Front Immunol. 2023 Jul 31;14:1223817. doi: 10.3389/fimmu.2023.1223817. eCollection 2023.https://doi.org/10.3389/fimmu.2023.1223817

 

52.  Choi MY, Satoh M, Fritzler MJ. Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies. Curr Opin Rheumatol. 2023 Nov 1;35(6):383-394. doi: 10.1097/BOR.0000000000000957. PMID: 37503636.

 

53.  Choi MY, Chen I, Clarke AE, et al. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. Ann Rheum Dis. 2023 Jul;82(7):927-936. doi: 10.1136/ard-2022-223808. Epub 2023 Apr 21.

 

54.  Dobrowolski C, McGinley J, Fazzari M, Su J, Bingham KS, Anderson N, Ruttan L, Beaton DE, Wither JE, Tartaglia MC, Kakvan M, Bonilla D, Choi MY, Fritzler MJ, Diaz Martinez JP, Katz P, Green R, Putterman C, Touma Z. Association of mycophenolate and azathioprine use with cognitive function in systemic lupus. Rheumatology (Oxford). 2023 May 2;62(5):1860-1869. doi: 10.1093/rheumatology/keac540. PMID: 36135792; PMCID: PMC10152298.

 

55.  Choi MY, Malspeis S, Sparks J, Cui J, Yoshida K, Costenbader K. Association of Sleep Deprivation and the Risk of Developing Systemic Lupus Erythematosus among Women. Arthritis Care Res (Hoboken). 2023 Jun;75(6):1206-1212. doi: 10.1002/acr.25017. Epub 2022 Dec 29. PMID: 36094865; PMCID: PMC10008454.

 

56.  Barraclough ML, Diaz-Martinez JP, Knight A, Bingham K, Su J, Kakvan M, Grajales CM, Tartaglia MC, Ruttan L, Wither J, Choi MY, Bonilla D, Anderson N, Appenzeller S, Parker B, Katz P, Beaton D, Green R, Bruce IN, Touma Z. In-person versus virtual administration of the American College of Radiology gold standard cognitive battery in systemic lupus erythematosus: Are they interchangeable? Lupus. 2023 May;32(6):737-745. doi: 10.1177/09612033231168477. Epub 2023 Apr 10. PMID: 37036020; PMCID: PMC10189815.

 

57.  Tayer-Shifman OE, Yuen K, Green R, Kakvan M, Katz P, Bingham KS, Diaz-Martinez JP, Ruttan L, Wither JE, Tartaglia MC, Su J, Bonilla D, Choi MY, Appenzeller S, Barraclough M, Beaton DE, Touma Z. Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2023 Mar;75(3):569-577. doi: 10.1002/acr.24971. Epub 2022 Nov 17. PMID: 35724303.

 

58.  Hahn J, Malspeis S, Choi MY, Stevens E, Karlson EW, Lu B, Cui J, Yoshida K, Kubzansky L, Sparks JA, Costenbader KH. Association of Healthy Lifestyle Behaviors and the Risk of Developing Rheumatoid Arthritis Among Women. Arthritis Care Res (Hoboken). 2023 Feb;75(2):272-276. doi: 10.1002/acr.24862. Epub 2022 Oct 11. PMID: 35040282; PMCID: PMC9289074.

 

59.  Cui J, Malspeis S, Choi MY, Lu B, Sparks JA, Yoshida K, Costenbader KH. Risk prediction models for incident systemic lupus erythematosus among women in the Nurses' health study cohorts using genetics, family history, and lifestyle and environmental factors. Semin Arthritis Rheum. 2023 Feb;58:152143. doi: 10.1016/j.semarthrit.2022.152143. Epub 2022 Nov 25. PMID: 36481507; PMCID: PMC9840676.

 

60.  Marchand NE, Choi MY, Oakes EG, Cook NR, Stevens E, Gomelskaya N, Kotler G, Manson JE, Lasky-Su J, Mora S, Lee IM. Over-the-Counter Fish Oil Supplementation and Pro-Resolving and Pro-Inflammatory Lipid Mediators in Rheumatoid Arthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2023 Jan 26:102542.

 

61.  Agbani EO, Mahe E, Chaturvedi S, Yamaura L, Schneider P, Barber MRW, Choi MY, Lee A, Skeith L. Platelets and neutrophils co-drive procoagulant potential in secondary antiphospholipid syndrome during pregnancy. Thromb Res. 2022 Dec;220:141-144. doi: 10.1016/j.thromres.2022.10.018. Epub 2022 Nov 3. PMID: 36368231.

 

62.  Amlani A, Choi MY, Buhler KA, Hudson M, Tarnopolsky M, Brady L, Schmeling H, Swain MG, Stingl C, Reed A, Fritzler MJ. Anti-Valosin-Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies. ACR Open Rheumatol. 2023 Jan;5(1):10-14. doi: 10.1002/acr2.11510. Epub 2022 Nov 14.

 

63.  Cardwell FS, Elliott SJ, Chin R, St Pierre Y, Choi MY, Urowitz MB, Ruiz-Irastorza G, Bernatsky S, Wallace DJ, Petri MA, Manzi S, Bae SC, Shin JM, Mak A, Cho J, Peschken CA, Ramsey-Goldman R, Fortin PR, Hanly JG, Pons-Estel BA, Nieto R, Askanase AD, Romero-Diaz J, Mosca M, Bruce IN, Rowbottom L, Mielczarek L, Tse K, Marion A, Cáhiz-González JC, Cattoni TG, Cornet A, Clarke AE. Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic. Lupus Sci Med. 2022 Oct;9(1):e000755. doi: 10.1136/lupus-2022-000755. PMID: 36283746; PMCID: PMC9606736.

 

64.  Cotton T, Fritzler MJ, Choi MY, Zheng B, Niaki OZ, Pineau CA, Lukusa L, Bernatsky S. Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis. Lupus. 2022 Oct;31(12):1477-1484. doi: 10.1177/09612033221122158. Epub 2022 Aug 26. PMID: 36018314; PMCID: PMC9580032.

 

65.  Choi MY, Costenbader KH. Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development. Front Immunol. 2022 Jun 3;13:890522. doi: 10.3389/fimmu.2022.890522. PMID: 35720390; PMCID: PMC9203849.

 

 

66.  Choi MY, Cook NR, Kotler G, Serhan CN, Tatituri R, Costenbader KH. Fish oil supplementation in patients with and without systemic lupus erythematosus: targeting pro-inflammatory and pro-resolving lipid mediators. Clin Exp Rheumatol. 2022 Nov;40(11):2196-2197. doi: 10.55563/clinexprheumatol/xxr27t. Epub 2022 Jul 21. PMID: 35894061.

 

67.  Gukova X, Hazlewood GS, Arbillaga H, [and 12 others, including Choi, MY]. Development of an Interdisciplinary Early Rheumatoid Arthritis Care Pathway. BMC Rheumatology. 2022. 2022 Jun; 6(1):35. doi: 10.1186/s41927-022-00267-x.  

 

68.  Choi MY and Weber B (co-first authors), Stevens E, Guan H, Ellrodt J, Oakes E, Di Carli M, Tedrow U, Sauer W, Costenbader KH. Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center. Rheumatology International. 2022 Oct;42(10):1767-1774. doi: 10.1007/s00296-022-05125-0. Epub 2022 Apr 16. PMID: 35430712; PMCID: PMC9013275.

 

69.  Choi MY, Clarke AE, Buhler K, Jung M, Mathew H, Zhang M, Cardwell FS, Waldhauser H, Fritzler MJ. Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort. Lupus Sci Med. 2022 Apr;9(1):e000667. doi: 10.1136/lupus-2022-000667. PMID: 35393285; PMCID: PMC8990260.

 

70.  Storwick JA, Brett A, Buhler K, Chin A, Schmeling H, Johnson N, Fritzler MJ, Choi MY. Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis. Autoimmun Rev. 2022 Jun;21(6):103086. doi: 10.1016/j.autrev.2022.103086. Epub 2022 Apr 6. PMID: 35398272.

 

71.  Choi MY, Clarke AE, Urowitz M, et al. Longitudinal Analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Annals of the Rheumatic Diseases. 2022 Aug;81(8):1143-1150. doi: 10.1136/annrheumdis-2022-222168. Epub 2022 Mar 25. PMID: 35338033; PMCID: PMC10066935.

 

72.  Ma C and Choi MY. Integrating Novel Therapies into the Management Paradigm for Moderate-to-Severe Ulcerative Colitis: Challenges and Opportunities. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):110-112. doi: 10.1016/S2468-1253(21)00432-5.

 

73.  Moran C, Collins L, Beydoun N, Mehta P, Fatade Y, Isiadinso I,  Lewis T, Weber B, Goldstein J, Ofotokun I, Quyyumi A, Choi MY, Titanji K, and Lahiri C. Cardiovascular Implications of Immune Disorders in Women. Circulation Research. 2022 Feb;130(4):593-610. doi: 10.1161/CIRCRESAHA.121.319877.

 

74.  Choi MY, Hahn J, Malspeis S, Stevens E, Karlson E, Sparks J, Yoshida K, Kubzansky L, Costenbader K. Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus. Arthritis & Rheumatology 74.2 (2022): 274-283.

 

75.  Moran LV, Tsang ES, Ongur D, Hsu J, Choi MY.  Geographical variation in hospitalization for psychosis associated with cannabis use and cannabis legalization in the United States. Psychiatry Research. 2022 Jan;308:114387. https://doi.org/10.1016/j.psychres.2022.114387

 

76.  Storek J, Kanji JN, Choi MY, Kalra A, Chaudhry A, Jamani K, Dharmini-Khan P, and Khan FM. Mild clinical course of SARS-Coronavirus-2 infection early posttransplant in patients with adoptively transferred antibody response. Bone Marrow Transplantation. Jan 2022;57(1):119-121. doi: 10.1038/s41409-021-01489-2.

 

77.  Yuen K, Beaton D, Bingham K, Katz P, Su J, Diaz Martinez JP, Tartaglia MC, Ruttan L, Wither JE, Kakvan M, Anderson N, Bonilla D, Choi MY, Fritzler MJ, Green R, Touma Z. Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus. Lupus. 2022 Jan;31(1):45-54. doi: 10.1177/09612033211062530. Epub 2021 Dec 27. PMID: 34957878; PMCID: PMC8793300.

 

78.  Mathew H, Choi MY, Buhler K, Gukova X, Cardwell FS, Waldhauser H, Clarke AE, Fritzler MJ. SARS-CoV-2 Seroprevalence, Seroconversion and Neutralizing Antibodies in a Systemic Lupus Erythematosus Cohort and Comparison to Controls. Lupus. Dec 2021; 30(14):2318-2320. doi: 10.1177/09612033211063793.

 

79.  Bingham K, DiazMartinez J, Green R, Tartaglia M, Ruttman L, Su J, Wither JE, Kakvan M, Anderson N, Bonilla D, Choi MY, Fritzler MJ, Beaton DE, Katz P and Touma Z. Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 2021 Dec;51(6):1186-1192. doi: 10.1016/j.semarthrit.2021.09.008.

 

80.  Tani C, Zucchi D, Haase I, Larosa M, Crisafulli F, Strigini FAL, Monacci F, Elefante E, Mucke J, Choi MY, Andreoli L, Iaccarino L, Tincani A, Doria A, Fischer-Betz R, Mosca M. Are remission and low disease activity state ideal targets for pregnancy planning in Systemic Lupus Erythematosus? A multicentre study. Rheumatology (Oxford). 2021 Dec 1;60(12):5610-5619. doi: 10.1093/rheumatology/keab155. PMID: 33590843.

 

81.  He JW, Diaz Martinez JP, Bingham K, Su J, Kakvan M, Tartaglia MC, Ruttan L, Beaton D, Wither J, Choi MY, Fritzler MJ, Anderson N, Bonilla D, Green R, Katz P, Touma Z. Insight into intraindividual variability across neuropsychological tests and its association with cognitive dysfunction in patients with lupus. Lupus Sci Med. 2021 Oct;8(1):e000511. doi: 10.1136/lupus-2021-000511. PMID: 34610995; PMCID: PMC8493902.

 

82.  Choi MY, Hahn J, Malspeis S, Stevens EF, Karlson EW, Sparks JA, Yoshida K, Kubzansky L, Costenbader KH. Reply. Arthritis Rheumatol. 2021 Oct; 74(3):543-544. https://doi.org/10.1002/art.41990

 

83.  Choi MY, Li D, Feldman CH, Yoshida K, Guan H, Kim SC, Everett BM, Costenbader KH. Comparative Risks of Cardiovascular Disease Events among SLE Patients receiving Immunosuppressive Medications. Rheumatology (Oxford). 2021 Aug 2;60(8):3789-3798. https://doi.org/10.1093/rheumatology/keaa862.

 

84.  Yuen K, Green R, Bingham K, Ruttan L, Lee-Kim V, Tartaglia MC, Anderson M, Zandy M, Choi MY, Fritzler MJ, Wither JE, Beaton DE, Katz P, Touma Z. Metrics and Definitions Used in the Assessment of Cognitive Impairment in Systemic Lupus Erythematosus: A Systematic Review. Seminars in Arthritis and Rheumatism. 2021 Aug, 51(4):819:830.  https://doi.org/10.1016/j.semarthrit.2021.05.018.

 

85.  Fritzler MJ, Choi MY, Satoh M, Mahler M. Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond. Frontiers in Immunology. 2021 May 27;12:679613. doi: 10.3389/fimmu.2021.679613.

 

86.  Mathew HR, Choi MY, Parkins MD, Fritzler MJ. Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic. BMC Pulm Med, 2021 May;21(1):173. doi: 10.1186/s12890-021-01528-0. PMID: 34016096

87.  Choi MY, Clarke AE, Fritzler MJ. Do anti-DFS70 antibodies temper disease activity and progression in SLE? Lupus 2021 Apr;30(5):852-853.  doi: 10.1177/0961203321990439

 

88.  Ma C, Ho SKM, Singh S, and Choi MY. Gender Disparities in Food Security, Dietary Intake and Nutritional Health in the United States. American Journal of Gastroenterology. 2021 Mar 1;116(3):584-592. doi: 10.14309/ajg.0000000000001118.

 

89.  Maltez N, Choi MY, Troyanov Y, Wang M, Jantz M, Fritzler MJ, Baron M, Hudson M, the Canadian Scleroderma Research Group. Trigeminal neuralgia in systemic sclerosis. Seminars in Arthritis and Rheumatism. 2021 Feb;51(1): 318-323. https://doi.org/10.1016/j.semarthrit.2021.01.001

90.  Amlani A, Choi MY, Stingl C, Reed A, Stevens AM, et al. A Serologic Study of Anti-NT5c1A Autoantibodies in Juvenile Dermatomyositis and Other Pediatric Autoimmune Rheumatic Diseases. J Rheumatol Res. 2021 Jan;3(2):172-178.

 

91.  Choi MY, Cui J, Costenbader K, Rydzewski D, Bernhard L, Schur P. Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis. Lupus Science & Medicine. 2020 Nov;7(1):e000431. doi: 10.1136/lupus-2020-000431

 

92.  Choi MY, Ma C. Making a big impact with small datasets using machine-learning approaches. The Lancet Rheumatology. 2020 Aug;2(8):e451-e452. DOI:10.1016/S2665-9913(20)30217-4

 

93.  Fritzler M, Clarke A, Choi MY, St. Pierre Y, Systemic Lupus International Collaborating Clinics (SLICC) co‐authors. Response: Not Positive About ANA‐Negative Lupus. Arthritis Care & Research. 2020 May;72(5):734-735

 

94.  Choi MY, Fitzpatrick RD, Buhler K, Mahler M, Fritzler M. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. Autoimmunity Reviews. 2020 Mar;19(3):102463. doi: 10.1016/j.autrev.2020.102463.

 

95.  Choi MY, Butler E, Clarke A, Girard LP, Gibson P, Skeith L. Managing pregnancy-associated clinical emergencies in systemic lupus erythematosus: a case-based approach. Expert Review of Clinical Immunology 2020 Jan;16(1):5-22. doi: 10.1080/1744666X.2019.1699057.

 

96.  Tayer‐Shifman OE, Green R, Beaton D, Ruttan L, Wither JE, Tartaglia MC, Kakvan M, Lombardi S, Anderson N, Su J, Bonilla D, Zandy M, Choi MY, Fritzler M, Touma Z. Validity evidence supports the use of automated neuropsychological assessment metrics as a screening tool for cognitive impairment in lupus. Arthritis Care & Research (Hoboken). 2020 Dec;72(12):1809-1819. doi: 10.1002/acr.24096.

 

97.  Schmeling H, Chomistek K, Choi MY, and Fritzler M. Dense Fine Speckled Autoantibodies (DFS70) Titers Decrease in Successful Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. 2019. JRR, 2(1): 84-86

 

98.  Choi MY and Fritzler MJ. Autoantibodies in SLE: Prediction and the p Value Matrix. Lupus. 2019 Oct;28(11):1285-1293. doi:10.1177/0961203319868531.

 

99.  Amlani A, Choi MY, Tarnopolsky M, Brady L, Clarke A, Garcia De La Torre I, Mahler M, Schmeling H, Barber C, Jung M, and Fritzler MJ. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis. Frontiers Immunology. 2019 Apr 9;10: 745. doi: 10.3389/fimmu.2019.00745.

 

100.        Choi MY and Fritzler M. Challenges and Advances in SLE Autoantibody Detection and Interpretation. Current Treatment Options in Rheumatology. 2019 Jun 15;5:147-67. https://doi.org/10.1007/s40674-019-00122-0

 

101.        Miyachi K, Ihara A, Ihara M, Yamamoto K, Sasse B, Igarashi T, Mashiba S, Choi MY, Fritzler M. Anti-DFS70 Autoantibodies in Japanese Women at Different Menstrual Stages. J Rheumatol Res, 2019; 1(1): 24-32.

 

102.        Fritzler MJ, Martinez-Prat L, Choi MY, Mahler M. The Utilization of Autoantibodies in Approaches to Precision Health. Frontiers Immunology. 2018 Nov 16;9: 2682. doi: 10.3389/fimmu.2018.02682.

 

103.        Choi MY, Clarke A, St. Pierre Y, [and 39 others, including Fritzler MJ]. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902. doi: 10.1002/acr.23712.

 

104.        Choi MY, Barnabe C, Barber C, Bykerk V, Pope J, Hazlewood G. Pragmaticism of Randomized Controlled Trials of Biologic Treatment with Methotrexate in Rheumatoid Arthritis: A Systematic Review. Arthritis care & research. 2019 May;71(5): 620-628. doi: 10.1002/acr.23620.

 

105.        Fritzler M, Hudson M, Choi MY, Mahler M, Wang M, Bentow C, Milo J, Baron M. Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype. Journal of Autoimmunity. 2018 Mar;17(3):267-275. doi: 10.1016/j.autrev.2018.01.006.

 

106.        Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE. A review on SLE and malignancy. Best Practice & Research Clinical Rheumatology. 2017 Jun;31(3):373-396. doi: 10.1016/j.berh.2017.09.013.

 

107.        Fritzler MJ, Choi MY, Mahler M. The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies. The Journal of rheumatology. 2018 Mar;45(3):444-445. doi: 10.3899/jrheum.170258.

 

108.        Olsen, NJ, Choi MY, Fritzler MJ. Emerging Technologies in Autoantibody Testing for Rheumatic Diseases. Arthritis Research & Therapy. 2017 Jul 24;19(1):172. doi: 10.1186/s13075-017-1380-3.

 

109.        Choi MY, Clarke A, St. Pierre Y et al. The Prevalence of Anti-DFS70 Antibodies in an International Inception Cohort of Systemic Lupus Erythematosus. Lupus. 2017 Sep;26(10): 1051-1059. doi: 10.1177/0961203317692437.

 

110.        Hudson M, Luck Y, Stephenson M, Choi MY, Wang M, Baron M, Fritzler MJ, Canadian Scleroderma Research Group. Anti-HMGCR antibodies in systemic sclerosis. Medicine. 2016 Nov;95(44): e5280. doi: 10.1097/MD.0000000000005280.

 

111.        Choi MY, Fritzler M. Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis. Current Opinion in Rheumatology. 2016 Nov;28(6):586-594. doi: 10.1097/BOR.0000000000000325.

 

112.        Fritzler MJ, Choi MY. Editorial: Are Autoantibodies Involved in the Pathogenesis of Systemic Sclerosis? Arthritis & Rheumatology. 2016 Sep;68(9):2067-70. doi: 10.1002/art.39727.

 

113.        Musset L, Allenbach Y, Benveniste O, [and 29 others, including Choi, MY]. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmunity reviews. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023.

 

114.        Choi MY, Barber M, Barber C, Clarke A, Fritzler M. Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care. Lupus. 2016 Jul;25(8):838-849. doi: 10.1177/0961203316640367.

 

115.        Choi MY, Mintz M, Bates D. Interaction between Warfarin and Apple Juice. The Canadian journal of hospital pharmacy. 2016 Mar 1;69(1):42-44. doi: 10.4212/cjhp.v69i1.1522.

 

116.        Peerani F, Choi MY, Weinkauf J, Fedorak R, Halloran B. Patients with Active Luminal Crohn's Disease Have Evidence of Significant Functional and Clinical Pulmonary Involvement. Inflammatory bowel diseases. 2015 Aug;21(8):1817-24. doi: 10.1097/MIB.0000000000000442.

 

117.        Nanji JA, Choi MY, Ferrari R, Lyddell C, Russell A. Time to Consultation and Disease-modifying Antirheumatic Drug Treatment of Patients with Rheumatoid Arthritis—Northern Alberta Perspective. The Journal of Rheumatology. 2012 Apr;39(4):707-11. doi: 10.3899/jrheum.110818.

 

118.        Choi MY, Sutherland G. Surgical performance in a virtual environment. On the Horizon. 2009 Sep 25;17(4):345-55. https://doi.org/10.1108/10748120910998335

 

 

Non-Peer Reviewed

 

1.     Choi MY, Andreiuk J. A Leg Up on Cellulitis. Fairviewpost.com. http://www.fairviewpost.com/2013/07/10/a-leg-up-on-cellulitis, July 10, 2013.

 

2.     Choi MY, Li W, Hayward R. Virtual Medicine: A Case of Hematemesis. CHEC-CESC Virtual Patient Challenge Competition. https://sites.google.com/a/ualberta.ca/uofavirtualpatient/, January 2013.

 

Book Chapter

 

1.      Choi MY and KH Costenbader. “SLE”. Women and Health: Volume 2.  Elsevier Science (2026).

 

2.      Choi MY and KH Costenbader. "Prognosis and mortality of systemic lupus erythematosus." Dubois' Lupus Erythematosus and Related Syndromes (2025): 864-879.

 

3.      Choi MY, Fritzler M. Immunodeficiency, Infection and Autoimmune Diseases. Report on the 13th Dresden Symposium on Autoantibodies, September 27‐30, 2017: Trends in autoantibody testing: The imperative of autoimmune disease prevention. Lengerich, Germany: Pabst Science Publishers. 2017; 11: 198-208. 

 

4.      Choi MY, Fritzler M. Challenges and Advances in SLE Autoantibody Detection and Interpretation. Outcome Measures and Metrics in Systemic Lupus Erythematosus. 2020. Springer Nature. 2021; 3:67-91

 

5.      Choi MY, Fritzler M, and Mahler M. Development of multi-omics approach in autoimmune diseases. In "Precision Medicine and Artificial Intelligence: The Perfect Fit for Autoimmunity" (M. Mahler, ed.), San Diego, Elsevier. 2020; 8:189-196.

 

Abstracts

 

1.     Chubbs K, Ye C, Jamal S, Hudson M, Pope J, Appleton CT, Hoa S, et al [including Choi MY]. Validation of the Health Assessment Questionnaire–Disability Index in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis. J Rheumatol. 2026;53(Suppl 1):36-37.

 

2.     Farhat R, Choi M, Fritzler M, Medina MDCZ, Bae SC, Clarke A, Barber M, et al. Adverse Pregnancy Outcomes Within the Lupus in Pregnancy (Legacy) Cohort: Anti-Phosphatidylserine/Prothrombin IgG Antibodies Are Stronger Predictors Than Lupus Anticoagulant. J Rheumatol. 2026;53(Suppl 1):26.

 

 

3.     Holt J, Mosher D, Seni J, Crowshoe L, Sciore P, Sciascia S, Clarke A, et al [including Choi MY]. Feasibility of Saliva-Based Autoantibody Detection in Systemic Lupus Erythematosus. J Rheumatol. 2026;53(Suppl 1):27-28.

 

4.     Barreth N, Choi M, Leclair V, Hudson M, Toro CM, St-Pierre Y, Clarke A, et al. Sialic Acid-Binding Ig-Like Lectin 1: A Serological Biomarker for Pulmonary Involvement in Idiopathic Inflammatory Myopathies. J Rheumatol. 2026;53(Suppl 1):14-15.

 

5.     Alkadri S, Li M, Cheema K, Muruve D, St-Pierre Y, Clarke A, Sciore P, et al [including Choi MY]. Novel Diagnostic and Prognostic Urinary Biomarker Model for Lupus Nephritis and Renal ANCA-Associated Vasculitis. J Rheumatol. 2026;53(Suppl 1):31-32.

 

6.     Choi M, Horisberger A, Oakes E, Dillon E, Adejoorin I, Caldropoli J, et al. Autoantibody Clusters and SIGLEC1 are Predictive of Systemic Lupus Erythematosus Development. J Rheumatol. 2026;53(Suppl 1):73.

 

7.     Krustev E, Kutlubrek E, Pun A, Fritzler M, Zochodne D, Choi M, et al. Kinesin Family Member 20B is Upregulated in a Murine Peripheral Nerve Injury Model. J Rheumatol. 2026;53(Suppl 1):64.

 

8.     Jessen C, Schnitzer M, Larché M, Choi M, Osman M, Pope J, Thorne C, et al. Immunosuppressive therapy and risk of incident pulmonary arterial hypertension in systemic sclerosis: results from the Canadian Scleroderma Research Group. J Scleroderma Relat Disord. 2026;11(Suppl 1):A156-A157.

 

9.     Jessen C, Berger C, Larché M, Choi M, Osman M, Pope J, Thorne C, et al. Characterization of early pulmonary arterial hypertension in systemic sclerosis: a Canadian Scleroderma Research Group cohort study. J Scleroderma Relat Disord. 2026;11(Suppl 1):A157-A158.

 

10.  Hoa S, Da Silva MV, Rousseau M, Faucher C, Mu YC, Chalaoui J, et al al [including Choi MY]. Prognostic value of quantitative chest computed tomography for predicting progression of mild interstitial lung disease in systemic sclerosis: a multicentric nested case-control study. J Scleroderma Relat Disord. 2026;11(Suppl 1):A139.

 

11.  van Eeden C, Pope J, Mulder U, Redmond D, Reynolds E, Baron M, et al al [including Choi MY]. Oxygen-transport-cascade and dysregulated interferon signals are associated with severe fatigue in patients with systemic sclerosis. J Scleroderma Relat Disord. 2026;11(Suppl 1):A95-A96.

 

12.  Shen C, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, et al al [including Choi MY]. Anti-NOR-90 autoantibodies and clinical associations in systemic sclerosis: an international retrospective cohort study. J Scleroderma Relat Disord. 2026;11(Suppl 1):A99-A100.

 

13.  Goulet D, Guertin C, Larché M, Hudson M, Ferdinand I, Choi MY, et al. Distinct systemic sclerosis phenotypes related to race/ethnicity: an opportunity to personalize care. J Scleroderma Relat Disord. 2026;11(Suppl 1):A361.

14.  Hoa S, Goulet D, Kawano Y, Proudman S, Stevens W, Chung L, et al al [including Choi MY]. Predicting progression of mild interstitial lung disease in systemic sclerosis: an international retrospective cohort study. J Scleroderma Relat Disord. 2026;11(Suppl 1):A138.

 

15.  Nevskaya T, Larché M, Baron M, Hoa S, Choi M, Osman M, Thorne C, et al. Concomitant Sjögren’s syndrome as a marker for severe visceral disease in systemic sclerosis. J Scleroderma Relat Disord. 2026;11(Suppl 1):A324-A325.

 

16.  Michiels B, Vulsteke JB, Vanthuyne M, Choi M, Mohammed T, Lacout C, et al. Closing the seronegative gap in systemic sclerosis with immunoprecipitation–mass spectrometry: a multicentric international study. J Scleroderma Relat Disord. 2026;11(Suppl 1):A90-A91.

 

17.  Chubbs K, Ye C, Jamal S, Hudson M, Pope J, Appleton T, Hoa S, Saltman A, Himmel M, Maltez N, Khokhar F, Ladouceur A, Colmegna I, Choi MY, Elsayed M, Roberts J. Validation of the Health Assessment Questionnaire Disability Index in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/validation-of-the-health-assessment-questionnaire-disability-index-in-immune-checkpoint-inhibitor-induced-inflammatory-arthritis/. Accessed April 26, 2026.

 

18.  Williamson T, Shantz E, Elliott S, Sperling C, Costenbader K, Choi MY. Investigating Canadians’ information needs related to lupus: A Google Trends analysis of online search query data [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/investigating-canadians-information-needs-related-to-lupus-a-google-trends-analysis-of-online-search-query-data/. Accessed April 26, 2026.

 

19.  Kim Y, Guan H, Oakes E, Zhong K, Paudel M, Choi MY, Liao K, Weber B, Costenbader K. Cardiovascular Risk Prediction in Systemic Lupus Erythematosus: Comparing the PREVENT and SLECRISK Models [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/cardiovascular-risk-prediction-in-systemic-lupus-erythematosus-comparing-the-prevent-and-slecrisk-models/. Accessed April 26, 2026.

 

20.  Li M, Sciore P, Fritzler M, Clarke A, Ocampo W, Buhler k, Seni J, Crowshoe L, Mosher D, Choi MY. Dried Blood Spots for Remote ANA and Autoantibody Screening [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/dried-blood-spots-for-remote-ana-and-autoantibody-screening/. Accessed April 26, 2026.

 

21.  Horisberger A, Oakes E, Dillon E, Adejoorin I, Caldropoli J, Marks K, Sasaki T, Moghaddam F, Sciore P, Fritzler MJ, Rao D, Choi, M, Costenbader K. PO:02:053 Autoantibody clusters and SIGLEC1 are predictive of systemic lupus erythematosus development. Lupus Science & Medicine. 2026;13:. https://doi.org/10.1136/lupus-2026-el.128. Mar 2026.

 

22.  Choi MY, Moghaddam F, Sajadi M,  Clarke AE, Bernatsky S, Costenbader K, Chen I, Urowitz M, Hanly J, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón G, Van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanç M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase , Fritzler MJ and Aminghafari M.  Rheumatology Diagnostics Utilizing Artificial Intelligence (ANA Reader©) for ANA Pattern Identification and Titer Quantification. AMLI 2025. Minneapolis, Minnesota. August 2025.

 

23.  Li M*, Barreth N*, Cheema K, Muruve D, St.Pierre Y, Clarke A, Sciore P, Fritzler M, Choi MY. Novel Urinary Biomarker Model for Differentiating Lupus Nephritis and ANCA Associated Vasculitis. Poster Presentation. 16th International Congress on Systemic Lupus Erythematosus 2025.

 

24.  Shantz E, Williamson T, Elliott S, Sperling C and Choi M.  Investigating Canadian’s Information Needs Related to Lupus: a Google Trends Analysis of Online Search Query Data.  16th International Congress on Systemic Lupus Erythematosus 2025.

 

25.  Zhao N, Smargiassi A, Chen H, Choi M, Fritzler MJ, Touma Z, Awadalla P, Aviña-Zubieta A and Bernatsky S. Fine Particulate Matter Air Pollution and Antinuclear Antibody Positivity: The Ontario Health Study.16th International Congress on Systemic Lupus Erythematosus 2025.

 

26.  Moghaddam F*, Sajadi J, Clarke A, Bernatsky S, Costenbader K, Urowitz M, Hanly J, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Isenberg D, Rahman A, Merrill J, Fortin PR, Gladman DD, Bruce I, Petri M, Ginzler M, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, Van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Fritzler MJ, Aminghafari M and Choi MY. Machine Learning can Identify an Antinuclear Antibody Pattern that may Rule Out Systemic Autoimmune Rheumatic Diseases.  16th International Congress on Systemic Lupus Erythematosus 2025.

 

27.  Li JX, Hudson M, Ye C, Roberts J, Fifi-Mah A, Choi MY, Hoa S, Appleton CT, Pope J, Maltez N, Arreola LG, Obrzut A and Jamal S on behalf of the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO).  Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO). 16th International Congress on Systemic Lupus Erythematosus 2025.

 

28.  Neary E, Munoz-Grajales C, Wither J, Martinez JPD, Barraclough M, Bingham K, Kretzmann R, Tartaglia C, Ruttan L, Choi MY, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Whittall-Garcia L, Gladman D and Touma Z. Serum S100A8/A9, MMP-9 and IL-6 are associated with impairment in executive function, simple attention and processing speed in patients with systemic lupus erythematosus. 16th International Congress on Systemic Lupus Erythematosus 2025.

 

29.  Moghaddam F*, Ludwig T, Aminghafari M, Choi MY, Nicholls F. Analysis of the Implications of Lumbopelvic Alignment on the Alignment of the Cervical Spine. Canadian Rheumatology Association Annual Scientific Meeting 2025.

 

30.  Greenwood B, Jamal S, Hudson M, Roberts J, Appleton T, Fifi-Mah A, Himmel M, Pope, Saltman A, Arreola L, Choi MY, Khokhar F, Ladouceur A, Ye C. Description of Immune Checkpoint Inhibitor Associated Sicca-Like Syndrome from the Canadian Research Group of Rheumatology in Immuno-Oncology Database: A Case Series. Canadian Rheumatology Association Annual Scientific Meeting 2025.

 

31.  Guertin C, Bernatsky S, Larché M, Choi M, Osman M, Pope J, Thorne C, Hudson M, Hoa S, Distinct Systemic Sclerosis Phenotypes Related to Race/ethnicity: an Opportunity to Personalize Care? Canadian Rheumatology Association Annual Scientific Meeting 2025.

 

32.  Li G*, Barreth N*, Krustev E, Moran-Toro C, St-Pierre Y, Sciore P, Hudson M, Fritzler MJ, Leclair V, Choi MY, on behalf of the CIMS investigators. Addressing Complications of Complement Activation Product Evaluation In Autoimmune Inflammatory Myopathies. Poster Presentation. Canadian Rheumatology Association Annual Scientific Meeting 2025.

33.  Barreth N*, Krustev E, Moran-Toro C, Clarke A, St-Pierre Y, Sciore P, Fritzler MJ, Hudson M, Leclair V, Choi MY, on behalf of the CIMS investigators. Sialic Acid Binding Ig-like Lectin 1 is a Biomarker of Disease Activity in Autoimmune Inflammatory Myopathies. Oral Presentation. Canadian Rheumatology Association Annual Scientific Meeting 2025.

 

34.  Moghaddam F, Javad Sajadi M, Hou H, Clarke A, Bernatsky S, Hou H, Costenbader K, Fritzler MJ, Aminghafari, M, Choi MY, on behalf of the SLICC investigators. Machine Learning Can Identify An Antinuclear Antibody Pattern That May Rule Out Systemic Autoimmune Rheumatic Diseases. Canadian Rheumatology Association Conference 2025.

 

35.  Khan U, Hoa S, Choi M, Pope J. Is There Relevance of a Positive Rheumatoid Factor in Systemic Sclerosis? a Systematic Review of the Literature. Canadian Rheumatology Association Conference 2025.

 

36.  Choi MY, Moghaddam F, Sajadi M,  Clarke AE, Bernatsky S, Costenbader K, Chen I, Urowitz M, Hanly J, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón G, Van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanç M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase , Fritzler MJ and Aminghafari M.  Rheumatology Diagnostics Utilizing Artificial Intelligence (ANA Reader©) for ANA Pattern Identification and Titer Quantification. American College of Rheumatology Conference 2024.

 

37.  Moghaddam F, Tarnopolsky M, Leclair V, Hudson M, Mitchell R, Buhler K, Hatcher E, Zhang M, Dufour A, de Almeida L, Fritzler MJ and Choi MY. Sporadic Inclusion Body Myositis Novel Autoantibody and Biomarker Research Utilizing Proteome Microarray and Mass Spectrometry Proteomics Analysis. American College of Rheumatology Conference 2024.

 

38.  Krustev E, Fritzler MJ, Bernatsky S, St-Pierre Y, Vinet E, Pineau C, Mendel A, Kalache F, Grenier LP, Cotton T, Zahedi O and Choi MY. Anti-Myxovirus Resistance Protein 1: A Novel Biomarker for Autoimmune Myositis and Interstitial Lung Disease in Systemic Lupus Erythematosus. American College of Rheumatology Conference 2024.

 

39.  Neary E, Munoz-Grajales C, Wither , Martinez JPD, Barraclough M, Bingham K, Kretzmann R, Tartaglia MC, Ruttan L, Choi MY, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Garcia LPW, Gladman D and Touma Z. Novel Analytes Associated with Cognitive Impairment in Patients with Systemic Lupus Erythematosus: Serum S100A8/A9, MMP-9 and IL-6. American College of Rheumatology Conference 2024.

 

40.  Dobrowolski C, Martinez JPD, Bingham K, Barraclough M, Kretzmann R, Tartaglia MC, Ruttan L, Choi MY, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Wither J, Garcia LPW, Gladman  and Touma Z. Cognitive Impairment Prevalence and Most Affected Domains in Patients with SLE by the ACR Comprehensive Neuropsychological Battery. American College of Rheumatology Conference 2024.

 

41.  Willis R, Murthy V, Roye-Green K, Thees K, Choi MY Dier K, Fritzler MJ, Fink S, Nandakumar V, Snyder M and Tebo A. Binding Characteristics of Patient Clusters Among Anticardiolipin and Anti-β2-Glycoprotein I ELISA and Non-ELISA Assays: A Survey by the Association of Medical Laboratory Immunologists. American College of Rheumatology Conference 2024.

 

42.  Munoz-Grajales C, Barraclough M, Lauren Erdman L, Diaz Martinez J, Bingham K, Kakvan M, Kretzmann R, Tartaglia C, Ruttan L, Choi MY, Appenzeller S, Marzouk S,   Bonilla D, Katz P, Beaton D,  Goldenbergg A, Green R, Gladman D, Wither J, Touma Z. Association of Serum Analytes With SLE Cognitive Impairment Phenotypes Formed by Machine Learning: MMP-9,s100A8/a9, Il-6, Il-10, and NGAL. Canadian Rheumatology Association Conference 2024.

 

43.  Li J,  Marie Hudson M, Carrie Ye C,  Janet Roberts J, Aurore Fifi-Mah A, Choi MY,  Hoa S, Appleton T, Pope J, Maltez N,  Arreola L, Obrzut  A, Jamal S. Impact of Aging on Rheumatic Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors: Experience from The Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO). Canadian Rheumatology Association Conference 2024.

 

44.  Choi MY, Moghaddam, F, Sajadi M, Clarke AE, Bernatsky S, Costenbader K, Chen I, Urowitz M, Hanly J, Gordon C,  Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley MA, Rosalind Ramsey-Goldman21, Manzi S, Jönsen A, Alarcón G, Van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanç M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Fritzler MJ and Aminghafari M. Rheumatology Diagnostics Utilizing Artificial Intelligence (ANA Reader©) for ANA Pattern Identification and Titer Quantification. American College of Rheumatology Conference 2023.

 

45.  Moghaddam F, Tarnopolsky M, Leclair V, Hudson M, Mitchell R, Buhler K, Hatcher E, Zhang M, Dufour A, de Almeida L, Fritzler MJ and Choi MY. Sporadic Inclusion Body Myositis Novel Autoantibody and Biomarker Research Utilizing Proteome Microarray and Mass Spectrometry Proteomics Analysis. American College of Rheumatology Conference 2023.

 

46.  Krustev E, Fritzler MJ, Bernatsky S, St-Pierre Y, Vinet E, Pineau C, Mendel A, Kalache F, Grenier LP, Cotton T, Zahedi O and Choi MY. Anti-Myxovirus Resistance Protein 1: A Novel Biomarker for Autoimmune Myositis and Interstitial Lung Disease in Systemic Lupus Erythematosus. American College of Rheumatology Conference 2023.

 

47.  Neary E, Munoz-Grajales C, Wither J, Diaz Martinez JP, Barraclough M, Bingham K, Kretzmann R,  Tartaglia MC, Ruttan L, Choi MY, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Whittall Garcia LP, Gladman D and Touma Z. Novel Analytes Associated with Cognitive Impairment in Patients with Systemic Lupus Erythematosus: Serum S100A8/A9, MMP-9 and IL-6. American College of Rheumatology Conference 2023.

 

48.  Dobrowolski C, Diaz Martinez JP,  Bingham K, Barraclough M, Kretzmann R,  Tartaglia MC, Ruttan L, Choi MY, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Wither J, Whittall Garcia LP, Gladman D and Touma Z. Cognitive Impairment Prevalence and Most Affected Domains in Patients with SLE by the ACR Comprehensive Neuropsychological Battery. American College of Rheumatology Conference 2023.

 

49.  Willis R, Murthy V, Roye-Green K, Thees A, Choi MY, Dier K, Fritzler MJ, Fink S, Nandakumar V, Snyder M and Tebo A. Binding Characteristics of Patient Clusters Among Anticardiolipin and Anti-β2-Glycoprotein I ELISA and Non-ELISA Assays: A Survey by the Association of Medical Laboratory Immunologists. American College of Rheumatology Conference 2023.

 

50.  Waraich, J, Kline, GA, Choi, M Y, Sigal , RJ, Caughlin, C, Przybojewski, SJ, Leung. Angiotensin AT1 Receptor Type 1 (AT1) Autoantibodies in Patients with Primary Aldosteronism [oral presentation]. Obesity & Hypertension in Canada: Science to Solutions Conference April 2024.

 

51.  Yee J, Oakes E, Choi M, Feldman C, Karlson E, Costenbader K. Depression, Anxiety and Post-Traumatic Stress Disorder in Association with Cardiovascular Disease Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis in the All of Us Research Program [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

52.  Oakes E, Buhler K, Adejoorin I, Marks K, Dillon E, Ellrodt J, Yee J, Rao D, Choi M, Costenbader K. Post-COVID-19 Autoimmune Serologies and Immunophenotypes [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

53.  Munoz-Grajales C, Barraclough M, Diaz Martinez J, Su J, Bingham K, Kakvan M, Kretzmann R, Tartaglia C, Ruttan L, Choi M, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Green R, Wither J, Touma Z. Elevated Serum Levels of S100A8/A9 Discriminate Systemic Lupus Erythematosus Patients with Cognitive Impairment from Patients Without Impairment [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

54.  Oakes E, Ellrodt J, Choi M, Yee J, Guan H, Costenbader K. Adverse Events Among Patients with and Without Autoimmune Rheumatic Disease Prescribed SGLT2 Inhibitors [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

55.  Choi M, Guan H, Yoshida K, Kargere B, Ellrodt J, Stevens E, Cai T, Everett B, Weber B, Costenbader K. Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

56.  Yee J, Feldman C, Oakes E, Ellrodt J, Choi M, Karlson E, Costenbader K. Cost-related Medication Burden for Patients with and Without Systemic Autoimmune Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

57.  Li J, Hudson M, Ye C, Roberts J, Fifi-Mah A, Choi M, Hoa S, Appleton T, Pope J, Maltez N, Gonzalez Arreola L, Obrzut A, Jamal S. Impact of Aging on Rheumatic Immune-related Adverse Events Secondary to Immune Checkpoint Inhibitors: Experience from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO) [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

58.  Barraclough M, Munoz-Grajales C, Erdman L, Diaz Martinez J, Bingham K, Kakvan M, Kretzmann R, Tartaglia C, Ruttan L, Choi M, Appenzeller S, Marzouk S, Bonilla D, Katz P, Beaton D, Goldenberg A, Green R, Wither J, Touma Z. Association of Serum Analytes with SLE Cognitive Impairment Phenotypes Formed by Machine Learning: MMP-9, S100A8/A9, IL-6, IL-10, and NGAL [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023. 

 

59.  Choi M, Costenbader K, Fritzler M, St. Pierre Y, Urowitz M, Hanly J, Gordon C, Bae S, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley M, Ramsey-Goldman R, Manzi S, Jonsen A, Alarcón G, van Vollenhoven R, Aranow C, MacKay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Buyon J, Clarke A. Direct Health Care Costs Differ by SLE Autoantibody Machine Learning Clusters in an International Inception [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023. 

 

60.  Wei J, Tarnopolsky M, Hudson M, Mitchell R, Buhler K, Dufour A, de Almeida L, Fortin P, Boilard E, Becker Y, Hatcher E, Zhang M, Fritzler M, Choi M. Machine Learning Identifies New Sporadic Inclusion Body Myositis Endotypes Associated with Unique Autoantibody Profiles [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). American College of Rheumatology Conference 2023.

 

61.  Krustev E, Hanly J, Chin R, Buhler K, Cardwell F, Urowitz M, Gordon C, Bae S, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley M, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón G, van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, İnanç M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Buyon J, Fritzler M, Clarke A, Choi M. M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort [abstract]. Association of Medical Laboratory Immunologists Conference 2023.

 

62.  Wei J, Tarnopolsky T, Hudson M, Mitchell R, Dufour A, Almeida L, Fortin P, Boilard E, Becker Y, Buhler K, Hatcher E, Zhang M, Fritzler M, Choi MY. Machine Learning Analysis of Sporadic Inclusion Body Myositis Biomarkers [abstract]. Canadian Rheumatology Association Conference 2023

 

63.  Choi MY, Weber B. Guan, H, Yoshida, K, Li D, Eldrodt J, Stevens E, Cai A, Everett B, Costenbader K et al. Personalizing Cardiovascular Risk Prediction for SLE Patients [abstract]. Canadian Rheumatology Association Conference 2023

 

64.  Krustev E, Hanly JG, Chin R, Buhler K, Cardwell FS, Fritzler M, Clarke AE, Choi MY.  SLICC The Systemic Lupus Erythematosus International Collaborating Clinics. M-Phase Phosphoprotein 1 Autoantibodies as a Biomarker for Cranial Neuropathies in an International SLE Inception Cohort [abstract]. Canadian Rheumatology Association Conference 2023

 

65.  Ladouceur A, et al. [including Choi MY]. The Effect of Sex on Patients with Pre-existing Rheumatoid Arthritis and Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Data from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO) Prospective Cohort [abstract]. Canadian Rheumatology Association Conference 2023.

 

66.  Kheirkhah H, Benard-Seguin E, Kaminska E, Costello F, Warrian K, Choi MY. More than Meets the Eye: A Case of retinal vasculitis in SLE [abstract]. Canadian Rheumatology Association Conference 2022.

 

67.  Storwick J, Brett A, Buhler K, Chin A, Schmeling H, Johnson N, Choi MY, Fritzler MJ.  Prevalence and Titre Distribution of Antinuclear Antibodies in Juvenile Idiopathic Arthritis – A Systematic Review [abstract]. Canadian Rheumatology Association Conference 2022.

 

68.  Gukova K, Barber B, Hazlewood G, Arbillaga H, MacMullan P, Zimmerman G, Barnabe C, Choi MY, Barber M, Charlton A, Job B, Osinski K, Spencer N, Knott M, Pirani P. Formulation of an Interdisciplinary Care Pathway for Early Rheumatoid Arthritis [abstract]. Canadian Rheumatology Association Conference 2022.

 

69.  Cardwell F, Elliott E, Chin R, Rowbottom L, St. Pierre Y, Choi MY, Urowitz M, Ruiz-Irastorza G, Bernatsky S, Petri M,  Peschken C, Ramsey-Goldman R, Fortin P, Bae SC, Mak A, Hanly J, Askanase A, Romero-Diaz J, Pons-Estel B, Bruce I, Wallace D, Clarke A. Investigating the Determinants of Accessing Social and News Media and Experiencing Negative Impacts during COVID-19 in an International SLE Sample [abstract]. Canadian Rheumatology Association Conference 2022.

 

70.  Cardwell F, Elliott S, Choi MY, Chin R, St. Pierre Y, Rowbottom L, Urowitz M, Ruiz-Irastorza G, Bernatsky S, Petri M, Manzi S, Peschken C, Ramsey-Goldman R, Fortin P, Bae  SC, Mak A, Hanly J, Askanase A, Romero-Diaz J, Pons-Estel B, Bruce I, Wallace D, Clarke AE. Health Information Use by SLE Patients Pre and During COVID-19 [abstract]. Canadian Rheumatology Association Conference 2022.

 

71.  Buhler K, Matthew H, Choi MY, Gukova K, Cardwell F, Waldhauser H, Clarke AE, Fritzler MJ. SARS-CoV-2 Seroprevalence, Seroconversion and Neutralizing Antibodies in a Systemic Lupus Erythematosus Cohort and Comparison to Controls [abstract]. Canadian Rheumatology Association Conference 2022.

 

72.  Diaz-Martinez J, Barraclough M, Yuen K, Tayer-Shifman O, Knight A, Bingham K, Su J, Kakvan M, Munoz C, Tartaglia M, Ruttan L, Wither J, Choi M, Bonilla D, Appenzeller S, Katz P, Beaton D, Green R, Touma Z. Assessing the Utility of the Montreal Cognitive Assessment as a Screening Tool for Cognitive Impairment in Patients with SLE Using a Bayesian Item-Response Theory Model [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

73.  Oakes E, Ellrodt J, Choi M, Guan H, Costenbader K. Prescribing Patterns of SGLT2 Inhibitors for Patients with Autoimmune Rheumatic Disease [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

74.  Oakes E, Ellrodt J, Alexander R, Conklin J, Choi M, Guan H, Tedeschi S, Sparks J, Case S, Hsu T, Solomon D, Jonsson A, Costenbader K. Autoimmune Serologies, Cell-Bound Complement Activation Products, and Autoimmune Rheumatic Disease Symptoms After COVID-19 Infection [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022. American College of Rheumatology Conference 2022.

 

75.  Munoz C, Barraclough M, Diaz-Martinez J, Su J, Bingham K, Kakvan M, Tartaglia M, Ruttan L, Choi M, Bonilla D, Appenzeller S, Katz P, Beaton D, Green R, Wither J, Touma Z. Serum Cytokine Profiling Reveals Elevated Levels of S100A8/A9 and MMP-9 in Systemic Lupus Erythematosus Patients with Cognitive Impairment Independently of Disease Activity and Inflammatory Markers [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

76.  Lawrence D, Su J, Knight A, Bingham K, Kakvan M, Tartaglia M, Ruttan L, Wither J, Choi M, Appenzeller S, Anderson N, Bonilla D, Katz P, Beaton D, Green R, Touma Z, Barraclough M. Systemic Lupus Erythematosus (SLE) Patients with Cognitive Impairment Experience More Fatigue Compared to Patients Without Impairment [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

77.  Barraclough M, Diaz-Martinez J, Knight A, Bingham K, Su J, Kakvan M, Munoz C, Tartaglia M, Ruttan L, Wither J, Choi M, Anderson N, Bonilla D, Appenzeller S, Parker B, Katz P, Beaton D, Green R, Bruce I, Touma Z. Evolution of Subjective Cognitive Impairment Overtime in SLE Patients: Bayesian Longitudinal Item Response Theory Modelling [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

78.  S. Jalaledin D, El Kamouni H, Albert A, Hoa S, Bourre-Tessier J, Rich E, Goulet J, Koenig M, Satoh M, Fritzler M, Choi M, Troyanov Y, Senécal, MD J, Landon-Cardinal O. Anti-RNPC3 Autoantibodies in Mixed Connective Tissue Disease Are Associated with Systemic Sclerosis Skin Involvement [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9).

 

79.  Li J, Mirizio E, Buhler K, Stevens A, Choi M, Schollaert-Fitch K, Torok K, Liu C, Fritzler M. Focused Clinical Correlation of Autoantibody Testing in Juvenile Systemic Sclerosis and Localized Scleroderma Using the Euroimmun™ Scleroderma Disease Profile [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

80.  Perera S, Su J, Bingham K, Kakvan M, Tartaglia M, Ruttan L, Wither J, Choi M, Appenzeller S, Beaton D, Bonilla D, Katz P, Green R, Barraclough M, Touma Z. Evidence on the Construct Validity of the Perceived Deficits Questionnaire Among Adult Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

81.  El Kamouni H, Albert A, Hoa S, S. Jalaledin D, Bourre-Tessier J, Rich E, Goulet J, Koenig M, Satoh M, Fritzler M, Choi M, Troyanov Y, Senécal J, Landon-Cardinal O. Anti-SMN Autoantibodies in Mixed Connective Tissue Disease Are Associated with a Scleromyositis Phenotype [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

82.  Krustev E, Hanly J, Chin R, Buhler K, Cardwell F, Urowitz M, Gordon C, Bae S, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley M, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón G, van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, İnanç M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Buyon J, Fritzler M, Clarke A, Choi M. M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

83.  Barraclough M, Diaz-Martinez J, Knight A, Bingham K, Su J, Kakvan M, Munoz C, Tartaglia M, Ruttan L, Wither J, Choi M, Bonilla D, Anderson N, Appenzeller S, Parker B, Katz P, Beaton D, Green R, Bruce I, Touma Z. Are Virtual Cognitive Assessments Comparable to In-person Assessments in a Systemic Lupus Erythematosus Cohort? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). American College of Rheumatology Conference 2022.

 

84.  Cotton T, Fritzler M, Choi MY, Zheng B, Zahedi Niaki O, Grenier L, Vinet E, Pineau C, Lukusa L, Kalache F, Bernatsky S. Serologic Phenotypes Distinguish SLE Patients with Myositis And/or Interstitial Lung Disease (ILD) [abstract].  American College of Rheumatology Conference 2021.

 

85.  Krustev E, Buhler K, Cardwell F, Fritzler M, Clarke A and Choi MY. Anti-MPP-1 Autoantibodies in Systemic Lupus Erythematosus: A Potential Biomarker for Neuropsychiatric Manifestations. American College of Rheumatology Conference 2021.

 

86.  Cardwell F, Elliott S, Choi MY, Chin R, St.Pierre Y, Rowbottom L, Urowitz M, Ruiz-Irastorza G, Bernatsky S, Petri M, Manzi S, Peschken C, Ramsey-Goldman R, Fortin PR, Shin J,  Bae SC, Cho J, Mak A, Hanly J, Askanase A, Romero-Diaz J, Nieto R, Pons-Estel BA, Bruce IN, Wallace D and Clarke A. Health Information Use by SLE Patients Pre and During COVID-19. American College of Rheumatology Conference 2021.

 

87.  Barraclough M, Erdman L, Knight A, Diaz-Martinez J, Bingham K, Su J, Kakvan M, Tartaglia M, Ruttan L, Wither J, Choi MY, Fritzler M, Bonilla D, Beaton D, Parker B, Green R, Katz P, Bruce I, Touma Z. SLE Phenotypes Formed from Machine Learning and Their Associations with Cognitive Impairment [abstract]. American College of Rheumatology Conference 2021.

 

88.  Cardwell F, Elliott S, Chin R, Rowbottom L, St.Pierre Y, Choi MY, Urowitz M, Ruiz-Irastorza G, Bernatsky S, Petri M, Manzi S, Peschken C, Ramsey-Goldman R, Fortin P, Shin J, Bae S, Cho J, Mak A, Hanly J, Askanase A, Romero-Diaz J, Nieto R, Pons-Estel B, Bruce I, Wallace D, Clarke A. Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample [abstract].   American College of Rheumatology Conference 2021.

 

89.  Dobrowolski C, Su J, McGinley J, Fazzari M, Bingham K, Anderson N, Beaton D, Ruttan L, Wither J, Tartaglia M, Kakvan M, Bonilla D, Choi MY, Fritzler M, Katz P, Green R, Putterman C, Touma Z. Association of Mycophenolate and Azathioprine Use with Cognitive Function in SLE [abstract]. American College of Rheumatology Conference 2021.

 

90.  Gupta A, Johnson S, Su J, Knight A, Diaz-Martinez J, Bingham K, Kakvan M, Tartaglia M, Ruttan L, Wither J, Choi MY, Fritzler M, Bonilla D, Beaton D, Katz P, Green R, Touma Z. Association of Subjective Cognitive Report Using PDQ-20 to a Neuropsychological Battery in a Cohort of SLE Patients [abstract].  American College of Rheumatology Conference 2021.

 

91.  He J, Diaz-Martinez J, Bingham K, Su J, Kakvan M, Tartaglia M, Ruttan L, Beaton D, Wither J, Choi MY, Fritzler M, Anderson N, Bonilla D, Green R, Katz P, Touma Z. Insight into Intraindividual Variability Across Neuropsychological Tests and Its Association with Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus [abstract]. American College of Rheumatology Conference 2021.

 

92.  Li J, Mirizio E, Buhler K, Choi MY, Hou H, Werner G, Sanyal A, Schollaert-Fitch K, Fritzler M, Torok K. Autoantibody Testing in Juvenile Localized Scleroderma and Systemic Sclerosis: Comparing Antibody Profiles and Clinical Correlations [abstract]. American College of Rheumatology Conference 2021.

 

93.  Cui J, Malspeis S, Choi MY, Lu B, Sparks J, Yoshida K, Costenbader K. Risk Prediction Models for Incident Systemic Lupus Erythematosus Using Lifestyle/Environmental Risk Factors and a Genetic Risk Score [abstract]. American College of Rheumatology Conference 2021.

 

94.  Choi MY, Cook N, Stevens E, Gomelskaya N, Kotler G, Manson J, Lasky-Su J, Tatituri R, Mora S, Lee I, Serhan C, Costenbader K. Fish Oil Supplementation and Pro-inflammatory and Pro-Resolving Lipid Mediators in Patients with and Without Systemic Lupus Erythematosus [abstract]. American College of Rheumatology Conference 2021.

 

95.  Gupta A, Johnson S, Su J, Bingham K, Knight A, Diaz-Martinez J, Kakvan M, Tartaglia M, Ruttan L, Wither J, Choi MY, Fritzler M, Bonilla D, Beaton D, Katz P, Green R, Touma Z. Studying Clusters of Patients with SLE According to Cognitive Function, Self-reported Outcomes, Disease Activity, and Clusters Dynamic over 1 Year [abstract]. American College of Rheumatology Conference 2021.

 

96.  Choi MY, Chen I, Clarke A, Fritzler M, Buhler K, Urowitz M, Hanly J, Gordon C, St.Pierre Y, Bae S, Romero-Diaz J, Sanchez-Guerrero F, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley M, Ramsey-Goldman R, Manzi S, Jnsen A, Alarcn G, van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Sontag D, Costenbader K. Identifying Clusters of Longitudinal Autoantibody Profiles Associated with Systemic Lupus Erythematosus Disease Outcomes [abstract]. American College of Rheumatology Conference 2021.

 

97.  Mathew H, Choi MY, Buhler K, Clarke A, Gukova X, Cardwell F, Fritzler M. SARS-CoV-2 Seroprevalence and Seroconversion in a Systemic Lupus Erythematosus Cohort and Comparison to General Population Controls [abstract]. American College of Rheumatology Conference 2021.

 

98.  Choi MY, Cook N, Stevens E, Gomelskaya N, Kotler G, Manson J, Lasky-Su J, Tatituri R, Mora S, Lee I, Serhan C, Costenbader K. Fish Oil Supplementation and Pro-inflammatory and Pro-Resolving Lipid Mediators in Patients with and Without Systemic Lupus Erythematosus [abstract]. Lupus 21st Century  Conference 2021.

 

99.  Choi MY, Chen I, Clarke A, Fritzler M, Buhler K, Urowitz M, Hanly J, Gordon C, St.Pierre Y, Bae S, Romero-Diaz J, Sanchez-Guerrero F, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Fortin P, Gladman D, Bruce I, Petri M, Ginzler E, Dooley M, Ramsey-Goldman R, Manzi S, Jnsen A, Alarcn G, van Vollenhoven R, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Sontag D, Costenbader K. Identifying Clusters of Longitudinal Autoantibody Profiles Associated with Systemic Lupus Erythematosus Disease Outcomes [abstract]. Lupus 21st Century 2021.

100.        Bingham K, Martinez J, Green R, Tartaglia C, Su J, Wither J, Kakvan M, Anderson N, Bonilla D, Choi MY, Fritzler M, Beaton D, Katz P, Touma Z. Longitudinal relationships between cognitive domains and mood and anxiety symptoms in SLE [abstract]. Canadian Rheumatology Association Conference 2021.

 

101.        Buhler K, Choi MY, Fritzler M, Wither J, Diaz-Martinez JP, Green R, Beaton D, Kakvan M, Ruttan L, Tartaglia M, Su J, Bonilla J, Anderson N, Katz P, Touma Z. Autoantibody Profiles of SLE Patients with Cognitive Impairment [abstract]. Canadian Rheumatology Association Conference 2021.

 

102.        He J, Martinez J, Bingham K, Su J, Kakvan M, Tartaglia C, Ruttan L, Beaton D, Wither J, Choi MY, Fritzler M, Anderson N, Bonilla D, Green R, Katz P, Touma Z, Insight into intraindividual variability across neuropsychological tests and its association with cognitive dysfunction in patients with systemic lupus erythematosus [abstract]. Canadian Rheumatology Association Conference 2021.

 

103.        Kwan A, Wither J, Martinez J, Green R, Beaton D, Bingham K, Kakvan M, Ruttan L, Tartaglia C, Fritzler M, Choi MY, Su J, Bonilla D, Anderson N, Katz P, Touma Z. Assessment of the impact of interferon levels on cognitive dysfunction in patients with SLE [abstract]. Canadian Rheumatology Association Conference 2021.

 

104.        Martinez J, Bingham K, Green R, Tartaglia C, Ruttan L, Su J, Wither J, Kakvan M, Anderson N, Bonilla D, Choi MY, Fritzler M, Beaton D, Katz P, Touma Z. Identifying cognitive impairment in patients with systemic lupus erythematosus using Bayesian statistical learning [abstract]. Canadian Rheumatology Association Conference 2021.

 

105.        Powell M, Choi MY, Barr S, Fritzler M. Systemic Lupus Erythematosus and Systemic Sclerosis Overlap with Paroxysmal Nocturnal Hemoglobinuria: A Case Report and Review of the Literature [abstract]. Canadian Rheumatology Association Conference 2021.

 

106.        Yuen K, Green R, Bingham K, Ruttan L, Lee-Kim V, Tartaglia C, Anderson M, Zandy M, Choi MY, Fritzler M, Wither J, Beaton D, Katz P, Touma Z. Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review [abstract]. Canadian Rheumatology Association Conference 2021.

 

107.        Yuen K, Kakvan M, Su J, Bingham K, Katz P, Martinez J, Tartaglia C, Ruttan L, Wither J, Anderson N, Bonilla D, Choi MY, Fritzler M, Beaton D, Touma Z.  Is the Montreal Cognitive Assessment (MoCA) a Suitable Screening Tool for Assessing Cognitive Impairment in Patients with Systemic Lupus Erythematosus (SLE) Compared to the American College of Rheumatology Neuropsychological Battery (ACR-NB)? [abstract]. Canadian Rheumatology Association Conference 2021.

 

108.        Cardwell F, Elliott S, Choi MY, Chin R, Peschken C, Urowitz M, Hanly J, Clarke A. Investigating SLE Patients' Access to Health Information Pre and During the COVID-19 Pandemic [abstract]. Canadian Rheumatology Association Conference 2021.

 

109.        Arreola L, Hudson M, Ye C, Roberts J, Fifi-Mah A, Appleton T, Colmegna I, Dutz J, Ennis D, Fritzler M, Choi MY, Himmel M, Hoa S, Maltez N, Pope J, Rottapel R, Saltman A,   Tisseverasinghe A, Jamal S. The Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO): The Development of a National Collaboration for Research, Advocacy, Education and Optimizing Patient Care in an Emerging and Complex Domain [abstract]. Canadian Rheumatology Association Conference 2021.

 

110.        Choi MY, Fritzler M, Costenbader K, et al. Dynamics of Anti-Nuclear Antibodies in a Longitudinal Study of a Large Systemic Lupus Erythematosus Cohort [abstract]. American College of Rheumatology Conference 2020.

 

111.        Bingham K, Diaz-Martinez JB, Kakvan M, Green R, Beaton D, Ruttan L, Tartaglia, Fritzler M, Choi MY, Su J, Bonilla D, Anderson N, Wither J, Katz P, Touma Z. Longitudinal Relationships Between Depression, Anxiety and Cognition in Lupus [abstract]. American College of Rheumatology Conference 2020.

 

112.        Moghaddam B, Green R, Beaton D, Bingham K, Kakvan M, Ruttan L, Tartaglia C, Fritzler M, Choi MY, Su, J, Diaz-Martinez JB, Bonilla D, Anderson N, Wither J, Katz P, Touma Z. Structural Validity of a Comprehensive Neuropsychological Battery Assessment of Cognitive Impairment in Systemic Lupus Erythematosus: Exploratory Factor Analysis Confirms Six Cognitive Domains [abstract]. American College of Rheumatology Conference 2020.

 

113.        Yuen K, Beaton D, Bingham K, Su J, Kakvan M, Diaz-Martinez JB, Tartaglia C, Ruttan L, Wither J, Anderson N, Bonilla D, Choi MY, Fritzler M, Katz P, Green R, Touma Z. Using Classification and Regression Tree Analysis to Assess the Construct Validity of the Automated Neuropsychological Assessment Metrics in the Assessment of Cognitive Impairment in SLE Compared to the ACT Neuropsychological Battery [abstract]. American College of Rheumatology Conference 2020.

 

114.        Choi MY, Stevens E, Guan H, Li D, Ellrodt J, Kargere B, Cai T, Yoshida K, Everett B, Costenbader K. Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus by Physician Global Assessment of Disease Activity [abstract]. American College of Rheumatology Conference 2020.

 

115.        Diaz-Martinez JP, Bingham K, Green R, Beaton D, Kakvan M, Ruttan L, Tartaglia C, Fritzler M, Choi MY, Su J, Bonilla D, Anderson N, Wither J, Katz P, Touma Z. Identifying Cognitive Impairment in Patients with Systemic Lupus Erythematous Using Hidden Markov Models: A Bayesian Approach [abstract]. American College of Rheumatology Conference 2020.

 

116.        Cardwell C, Elliott S, Choi MY, Chin R, Clarke A. Characterizing How SLE Patients Access Health Information Pre and During COVID-19 [abstract]. American College of Rheumatology Conference 2020.

 

117.        Hahn, Choi MY, Malspeis S, Stevens E, Karlson E, Yoshida K, Kubzansky L, Sparks J, Costenbader K. Healthy Lifestyle and Risk of Rheumatoid Arthritis in Women: A Prospective Cohort Study [abstract]. American College of Rheumatology Conference 2020.

 

118.        Choi MY, Hahn J, Malspeis S, Stevens E, Karlson E, Sparks J, Yoshida K, Kubzansky L, Costenbader K. A Combination of Healthy Lifestyle Behaviors Reduce Risk of Incident Systemic Lupus Erythematosus in the Nurses’ Health Studies [abstract]. American College of Rheumatology Conference 2020.

 

119.        Choi MY, Clarke A, Costenbader K, et al. Longitudinal Analysis of ANA Assay Performance in SLE from the SLICC Inception Cohort [abstract]. American College of Rheumatology Conference 2020.

 

120.        Kwan A, Wither J, Diaz-Martinez JP, Green R, Beaton D, Kakvan M, Ruttan L, Tartaglia C, Fritzler M, Choi MY, Su J, Bonilla D, Anderson N, Katz P, Touma Z. Assessment of the Impact of Interferon Levels on Cognitive Dysfunction in Patients with SLE [abstract]. American College of Rheumatology Conference 2020.

 

121.        Laestadius A, Choi MY, Fritzler M, Fifi-Mah A, Benseler S, Dantas J. Anti-Dense Fine Speckled (DFS) Autoantibodies in Autoinflammatory Vasculopathies [abstract]. American College of Rheumatology Conference 2020.

 

122.        Choi MY, Campbell E, Clarke AE, et al. Anti-NT5c1A Autoantibodies in Systemic Lupus Erythematosus [abstract]. The Journal of Rheumatology. June 1, 2019; 46: 33.

 

123.        Choi MY, Butler E, Clarke AE, Skeith L, Ma J. Threatening Thrombocytopenias in Lupus Pregnancies [abstract]. The Journal of Rheumatology. June 1, 2019; 46: 33-34.

124.        Choi MY, Clarke AE, Chin A, Jung M, Barber C, and Fritzler. Anti-Neutrophil Cytoplasmic Antibodies in Lupus Nephritis [abstract]. The Journal of Rheumatology. June 1, 2019; 46: 34.

 

125.        Choi MY, Brown R, Buhler K, Mahler M, Fritzler M. A Meta-Analysis of Anti-Ribosomal P Autoantibodies in Systemic Lupus Erythematosus: A Misunderstood Autoantibody [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

126.        Choi MY, Barber M, Fritzler M, et al. Is ANA-status at Disease Inception Associated with Long-term Damage Accrual and Direct and Indirect Health Care Costs in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

127.        Kakvan M, Green R, Ruttan L, Tartaglia M, Wither J, Zandy M, Bonilla D, Choi MY, Su J, Fritzler M, Beaton D, Touma Z. Performance of Montreal Cognitive Assessment (MoCA) in Screening for Cognitive Impairment in Patients with Lupus Compared to the Neuropsychological Battery [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

128.        Choi MY, Mirizio E, Quinteros F, Buhler K, Fritzler M, Torok K. Closing the Seronegative Gap in Pediatric Localized Scleroderma and Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

129.        Tayer-Shifman O, Green R, Beaton D, Ruttan L, Wither J, Tartaglia M, Kakvan M, Lombardi S, Anderson N, Su J, Bonilla D, Zandy M, Choi MY, Fritzler M, Touma Z. Can the Montreal Cognitive Assessment (MoCA) Improve the Automated Neuropsychological Assessment Metrics (ANAM) Performance in Screening for Cognitive Impairment in Lupus Patients? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

130.        Tayer-Shifman O, Green R, Beaton D, Ruttan L, Wither J, Tartaglia M, Kakvan M, Lombardi S, Anderson N, Su J, Bonilla D, Zandy M, Choi MY, Fritzler M, Touma Z. Validity Evidence Supports the Use of Automated Neuropsychological Assessment Metrics (ANAM) as a Screening Tool for Cognitive Impairment in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

131.        Beaton D, Green R, Ruttan L, Wither J, Tayer-Shifman O, Tartaglia M, Kakvan M, Anderson N, Su J, Zandy M, Choi MY, Fritzler M, Touma Z. Persistent Cognitive Impairment in Lupus Patients over 1 Year and Associated Factors [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

132.        Moghaddam B, Beaton D, Green R, Tartaglia M, Ruttan L, Kakvan M, Fritzler M, Choi MY, Zandy M, Su J, Vitti M, Bonilla D, Wither J, Lombardi S, Touma Z. Prevalence of Cognitive Impairment in an Inception Lupus Cohort as Assessed by a Comprehensive Neuropsychological Battery [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

133.        Zheng B, Wang M, Fritzler M, Choi MY, Baron M, Hudson M. Systemic Sclerosis Auto-antibody Profiles Predict Interstitial Lung Disease Onset but Not Progression [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

134.        Tayer-Shifman O, Beaton D, Green R, Ruttan L, Wither J, Tartaglia M, Kakvan M, Lombardi S, Anderson N, Su J, Bonilla D, Zandy M, Choi MY, Fritzler M, Touma Z. Describing Intra-Individual Cognitive Function Course over Time in Lupus Patients: Persistent and Fluctuating Cognitive Impairment, Affected Cognitive Domains, and Severity [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

 

135.        Mahler M, Roup F, Bentow C, Hudson M, Baron M, Choi MY, Fritzler M. Anti-RNPC-3 Antibodies Are Associated with Nuclear Speckled Immunofluorescence Pattern and Enriched in Triple Negative Systemic Sclerosis Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10).

136.        Choi MY, Campbell E, Clarke AE, et al 8 Anti-NT5c1A autoantibodies in systemic lupus erythematosus. Lupus Science & Medicine 2019;6: doi: 10.1136/lupus-2019-lsm.8

137.        Choi MY, Clarke AE, Chin A, et al. 20 Anti-neutrophil cytoplasmic antibodies in lupus nephritis Lupus Science & Medicine 2019;6:doi: 10.1136/lupus-2019-lsm.20

138.        Choi MY, Clarke AE, Jung M, et al. 58 Clinical and serological correlations of autoantibodies directed against RNP-C in systemic lupus erythematosus Lupus Science & Medicine 2019;6:doi: 10.1136/lupus-2019-lsm.158

 

139.        Choi MY, Campbell E, Clarke AE, Jung M, Barber C, St. Pierre Y, Fritzler MJ. Autoantibodies to M-Phase Phosphoprotein I (MPP-1: KIF20B) in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10).

 

140.        Porter A, Mirizio E, Fritzler MJ, Brown R, Choi MY, Schollaert-Fitch K, Liu C, Torok KS. Autoantibody Testing in Pediatric Localized Scleroderma (LS) [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10).

141.        Amlani A, Tarnopolsky M, Brady L, Garcia de la Torre I, Mahler M, Choi MY, Fritzler MJ. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10).

 

142.        Bernatsky S, Wang S, Choi MY, Weichenthal S, Hatzopoulou M, Fritzler M, Smargiassi A. Anti-Nuclear Antibodies (ANA) and Air Pollution: Ultrafine Particles and Ozone [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10).

143.        Mahler M, Bentow C, Milo J, Hudson M, Baron M, Choi MY, Fritzler M. Identification of an Immunodominant Epitope on Rnpc-3 As a Target of Autoantibodies in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10).

 

144.        Bernatsky S, Smargiassi A, Wang S, Choi MY, Weichenthal S, Hatzopoulou M, Fritzler M. Anti-nuclear antibodies (ANA) and air pollution: ultrafine particles and ozone. Lupus Science & Medicine Aug 2018, 5 (Suppl 2) A53; DOI: 10.1136/lupus-2018-lsm.86

 

145.        Choi MY, Campbell E, Clarke A, Jung M, Barber C, St. Pierre Y, Fritzler M. Autoantibodies to M-phase phosphoprotein I (MPP-1: KIF20B) in systemic lupus erythematosus. Lupus Science & Medicine Aug 2018, 5 (Suppl 2) A11-A12; DOI: 10.1136/lupus-2018-lsm.23

146.        Choi MY, Auza C, Mahler M, Aron E, Fritzler M. Interference of perinuclear anti‐neutrophil cytoplasmic antibody (P‐ANCA) detection by antinuclear antibody specificities [abstract]. The Journal of Rheumatology. July 2018; 45 (7) 975.

 

147.        Choi MY, St. Pierre Y, Urowitz M, Gladman DD, Bernatsky S, Vinet E, Pineau C, Hanly JG, Peschken CA, Fortin PR, Jung M, Barber C, Elliott S, Dixon J, Clarke AE. Economic Evaluation of Damage Accrual in a Nationwide Canadian SLE Cohort [abstract]. The Journal of Rheumatology. July 2018; 45 (7) 976.

148.        Choi MY, Baeza N, Arbillaga H, Chin A, Fritzler M, Autoantibodies to Double-Stranded DNA with a Discordant ANA Result: False Positive or Unique Epitopes? The Journal of Rheumatology. July 2018; 45 (7) 975.

 

149.        Choi MY, Mahler M, Jung M, Barber C, Clarke A, Fritzler M. Clinical Features Associated with Anti-Ro52/TRIM21 in SLE. The Journal of Rheumatology. July 2018; 45 (7) 975-976.

 

150.        Maltez N, Hudson M, Troyanov Y, Choi MY, Wang M, Fritzler MJ, Baron M, Smith D. Trigeminal Neuralgia in Systemic Sclerosis [abstract]. The Journal of Rheumatology. July 2018; 45 (7) 1012.

 

151.        Miyachi K, Ihar A, Sasse B, Choi MY, Fritzler M. The frequency of anti-DFS70 autoantibodies in Japanese women with peri- and post-menopausal arthralgia. Ann Rheum Dis, volume 77, supplement Suppl, year 2018, page A1753.

 

152.        Choi MY, St. Pierre Y, Urowitz M, Gladman DD, Bernatsky S, Vinet E, Pineau C, Hanly JG, Peschken CA, Fortin PR, Jung M, Barber C, Elliott S, Dixon J, Clarke AE. Economic Evaluation of Damage Accrual in a Nationwide Canadian SLE Cohort [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10).

 

153.        Maltez N, Hudson M, Troyanov Y, Choi MY, Wang M, Fritzler MJ, Baron M, Smith D. Trigeminal Neuralgia in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10).

 

154.        Mahler M, Bentow C, Milo J, Choi MY, Wang M, Budde P, Baron M, Hudson M, Fritzler MJ. Identification of a Sub-Population of Autoantibodies Targeting BICD2 Cross-Reacting with CENP-a Derived Peptides in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10).

 

155.        Mahler M, Bentow C, Milo J, Hudson M, Zucht H, Budde P, Wirtz D, Schulte-Pelkum J, Choi MY, and Fritzler M. SAT0372 Clinical and serological associations of autoantibodies to BICD2 as a novel marker for systemic sclerosis. Annals of the Rheumatic Diseases 2017; 76:911-912.

 

156.        Auza C, Mahler M, Choi MY, Aron E, Fritzler M. Interference of perinuclear anti‐neutrophil cytoplasmic antibody (P‐ANCA) detection by antinuclear antibody specificities. 13th Dresden Symposium on Autoantibodies, 2017, Dresden, Germany.

 

157.        Choi MY, Mahler M, Clarke A, Fritzler M. Anti‐Ro52/TRIM21: Unanswered questions. 13th Dresden Symposium on Autoantibodies, 2017, Dresden, Germany.

 

158.        Choi MY, Clarke AE, Hanly JG, Urowitz M, Romero-Diaz J, SLICC Investigators. The Prevalence and Determinants of Anti-DSF70 Antibodies in an International Inception Cohort of SLE patients. Annual Lupus Meeting, September 29-October 1, 2016, Armonk NY

 

159.        Mahler M, Bentow C, Milo J, Hudson M, Zucht HD, Budde P, Wirtz D, Schulte-Pelkum J, Choi M and Fritzler M. Clinical and serological associations of autoantibodies to BICD2 as a novel marker for systemic sclerosis. 70th European Union League Against Rheumatism, 2017, Madrid, Spain.

 

160.        Clarke A, Pike S, Choi MY, St. Pierre Y, Fritzler M. Correlation between Antibodies to the Phosphotidylserine/Prothrombin Complex and Conventional Antiphospholipid Antibodies. The Journal of Rheumatology. June 2017; 44(6).

 

161.        Pike S, Choi MY, Clarke A, Fritzler M. Does she or doesn’t she? A case of an atypical autoantibody profile in a patient with SLE. The Journal of Rheumatology. June 2017; 44(6).

 

162.        Choi MY, Clarke A, St. Pierre Y, Hanly J, Urowitz M, Pike S, Fritzler M. ANA Negative SLE: Re-evaluation in an International Inception Cohort of Systemic Lupus Erythematosus. The Journal of Rheumatology. June 2017; 44(6).

 

163.        Choi MY, Barnabe C, Pope J, Bykerk V, Barber C, Hazlewood G. A systematic review and appraisal of the ‘pragmaticism’ of randomized trials of biologic therapy in combination with methotrexate for rheumatoid arthritis. The Journal of Rheumatology. June 2017; 44(6).

 

164.        Choi MY, Fifi-Mah A, Mahler M, Auza C, Fritzler M. Anti-DFS70 autoantibodies in autoinflammatory vasculopathies. The Journal of Rheumatology. June 2017; 44(6). Also presented at Internal Medicine Resident’s Resident Research Day, Poster Presentation, Cumming School of Medicine, University of Calgary, Calgary, AB.

 

165.        Miller E, Lim R, Choi J, Stokes W, Bosch M, Choi MY. CPR Saves Lives: Teaching Hands-Only CPR at Community Sporting Events. Canadian Conference for Medical Education, 2016.

 

166.        Choi MY, Hanly J, Urowitz M, [and 42 others]. The Prevalence of Anti-DFS70 Antibodies in an International Inception Cohort of Systemic Lupus Erythematosus. The Journal of Rheumatology. 2016;43(6):16.

 

167.        Choi MY, Cooke L, Clarke A, Fritzler M, MacMullan P. The Wolf in the Water: Lupus vs. Lymphoma. The Journal of Rheumatology. 2016;43(6):17.

 

168.        Choi MY, Hanly J, Urowitz M, [and 42 others]. The Prevalence of Anti-DFS70 Antibodies in an International Inception Cohort of Systemic Lupus Erythematosus. American College of Rheumatology Conference 2016. Arthritis & Rheumatology. 2015;67.

 

169.        Akhavan P, Bykerk V, Sun Y, Choi MY, Pope J, Hitchon C, Boire G, Haraoui B, Thorne C, Tin D, Keystone E. FRI0091 Discrepancy between patient and physician global assessments in early rheumatoid arthritis (RA)–the need for swollen joint evaluation. Annals of the Rheumatic Diseases. 2013 Jun 1;71(Suppl 3):340.

 

170.        Peerani F, Halloran B, Choi MY, Hervas-Malo M, Weinkauf J, Fedorak R. Mo1711 Crohn's Disease Patients Treated with Infliximab Have Normal Pulmonary Function with Complete Remission but Diminished Pulmonary Function with Partial Response. Gastroenterology. 2012 May 31;142(5):S-666.

 

171.        Choi MY, Bykerk V, Sun Y, Akhavan P, Boire G, Thorne C, Pope J, Hitchon C, Haraoui B, Ferland D, Keystone E. Discrepancy between Patient and Physician Global Assessments of Disease Activity in Early and Established Rheumatoid Arthritis Patients. Canadian Rheumatology Association Annual Scientific Meeting 2012. Journal of Rheumatology. 2012 Aug 1 (Vol. 39, No. 8, pp. 1729-1730).

 

172.        McLeod K, Choi MY, Tang A, Truong K., Logan C. Red Bull: Effects on Cardiovascular Function and Development in the Chick Embryo. Institute of Child and Maternal Health Scientific Retreat, 2009.

 

173.        Choi MY, Ha C, Ho J, Cawthorpe D. Examining Parental Agreement and Compliance with Recommendations made by a Mental Health Clinician. The 4th Annual Mental Health Research Showcase, November 2008.

 

174.        Choi MY, Sutherland G. Surgical Performance in a Virtual Environment. The 38th Annual SAGSET Conference, 2008.

May Choi